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Phytosterols are steroid compounds structurally similar with cholesterol and vary in the
nature of carbon side chain. β-Sitosterol is commercially available in preparative amount
only as mixtures with other phytosterols. New semipreparative synthesis of pure βsitosterol and sidechain-modified phytosterols is discussed in this dissertation. This new
synthesis is achieved via a temporary masking of the stigmasterol 5,6-alkene as an
epoxide. Following performance of the desired modification, the alkene is regenerated
through a mild deoxygenation. Preparation of phytosterol esters for cholesterol
metabolism study is also discussed in this dissertation.

Singlet oxygen (1O2) is the lowest excited state of oxygen molecule. Due to its special
properties, 1O2 has been widely used as the oxidant in chemistry, biology, and medicine.
In the past decades, two major generation methods have been developed,
photosensitization and chemical generation. However, most of the reported chemical
generations require the water-rich media, which is associated with short 1O2 lifetime as a

major drawback. Therefore, there is a need for 1O2 generation from organic solvents. The
investigation of fragmentation of monoactivated derivatives of 1,1-dihydroperoxides is
discussed in this dissertation. This previously unobserved fragmentation can be
conducted in various organic solvents and generate high yield of 1O2. This reaction is
general for a range of skeletal frameworks and activating groups, and can be applied
directly to 1,1-dihydroperoxides via in situ activation. Kinetic and mechanistic
investigation suggests it involving rate-limiting formation of a peroxyanion, which
decompose to generate 1O2 via Grob-like process.
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Chapter 1
Synthesis of pure β-sitosterol and other phytosterols
(A portion of the results from this chapter have been published: Hang J, Dussault PH, A
concise synthesis of β-sitosterol and other phytosterols, Steroids, 2010, 75, 879-883)

1. Introduction

The term phytosterols refers to sterols and stanols synthesized in plants. The phytosterols
have the same tetracyclic core structure as mammalian sterols such as cholesterol but
differ in the presence or absence of a double bond at C22 and the nature of the
substitution at C24..

Some examples are shown in Figure 1. Stigmasterol 1 is an

unsaturated sterol, having one double bond in the sterol ring structure and one double
bond in the side chain. β-sitosterol 2 is an unsaturated sterol with one double bond in
sterol ring structure. Campesterol 4 is structurally similar to β-sitosterol but has a methyl
substituent at C24 position instead of an ethyl group. Stigmastanol 3 is a saturated sterol
both in sterol ring structure and side chain. So far, more than 200 sterols and related
compounds have been identified. 1 However, β-sitosterol 2 and campesterol 4 are
predominant, comprising 95% of isolated phytosterols.2
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Figure 1. Structures of stigmasterol (1), β-sitosterol (2), stigmastanol (3), campesterol (4).

In the past decades, phytosterols and their derivatives have been widely applied in
different areas such as the food and cosmetic industries, and have recently received a lot
of attention as nutraceutical additives. 3 Because of their ability to lower the level of
cholesterol in the human body, phytosterols have drawn greater interest and have been
widely used as food additives.4 Dietary intake of phytosterols is projected to increase in
western countries as consumers respond to health messages to increase vegetable oil
consumption at the expense of animal fats. 5 Besides the nutraceutical application,
phytosterols have also attracted attention as inhibitors of sarcoplasmic reticulum calcium
ATPase and transportation through potassium ion channels.6

As part of a collaboration investigating the structural influences of sterol ester structure
on uptake and processing, I needed preparative amounts of pure β-sitosterol However, βsitosterol is commercially available in preparative amounts only as mixtures with other
phytosterols, typically stigmasterol and campesterol. The few reported separations are
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relatively laborious.7 We therefore became interested in the synthesis of sitosterol from
stigmasterol, which is available in pure form.

Two routes have been reported for this

conversion.

The first route is illustrated in Scheme 1,8 and is based upon selective saturation of the
sidechain (∆22-23) alkene. Selective hydrogenation of the side chain Δ22-23 alkene with
Raney Nickel was found to produce β-sitosterol contaminated with the fully saturated
stigmastanol. Since β-sitosterol and stigmastanol are very similar in size, shape, and
polarity, it is very difficult if not impossible to isolate pure β-sitosterol from crude
hydrogenation products. However, treatment of the crude mixture of products with Br2
resulted in conversion of the the Δ5-6 alkene in β-sitosterol to a dibromide 5, which can be
separated from stigmastanol via column chromatography. Finally, the alkene group could
be regenerated via Zn/AcOH reduction of the dibromide, producing β-sitosterol as a pure
compound.

Raney Ni
+
H2
HO

HO

HO
1

2

3

Br2

Zn
EtOH/AcOH
HO

Br

HO

Br
5

2

4

Scheme 1. Synthetic route to pure beta-sitosterol via dibromide

The second route is illustrated in Scheme 2.9 This approach, which has been applied to
the synthesis of β-sitosterol and related sterols, circumvents the need for selective
hydrogenation by protecting the ∆5-6 alkene as a cyclopropyl carbinyl ether 7. Following
hydrogenation of the ∆22-23 side chain double bond with Pd/C as catalyst, solvolysis of the
cyclopropane reintroduces both the C3-alcohol and the ∆5-6 alkene.

Although this

approach is very useful as a means of obtaining very pure samples of β-sitosterol,
semipreparative applications were challenging in terms of removal of sterol methyl ether
byproducts 8.

TsCl, Pyridine
DMAP
HO

TsO
1

6

MeOH

+

MeO
OMe
8

7
Pd/C, H 2
EtOH

TsOH
Dioxane
HO
OMe
9

2

Scheme 2. Synthetic route to pure β-sitosterol via cyclopropyl carbinyl ether
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As discussed in more detail below, we reinvestigated the hydrogenation of stigmasterol
and developed an improved approach to sitosterol and sidechain-modified sitosterols
based upon temporary protection of the A-ring alkene as an epoxide.

2. Result and discussion

2.1 Stigmasterol hydrogenation with Raney Nickel
Raney nickel is a finely-divided gray powder which is composed of fine grains of a
nickel-aluminum alloy. It was developed in 1926 by Murray Raney, 10 and the original
purpose is to catalyze the hydrogenation of vegetable oils in industrial processes.
However, because of the special properties of massive irregular size pores in its three
dimension structure and large Brunauer-emmett-Teller surface area, 11 Raney nickel
exhibit high catalytic activity, and has been widely used as a heterogeneous catalyst in
organic synthesis.12

Raney nickel is prepared when a block of nickel-aluminum alloy is treated with
concentrated sodium hydroxide.13 The resulting reaction is shown in Equation 1.

NiAl2 + 6NaOH

Raney Nickel + 2Na3AlO3 + 3H2

Equation 1. Preparation of Raney Nickel

6

Fresh Raney Nickel was prepared according to standard procedure.10 Commercially
available pure stigmasterol was used to test the selective hydrogenation efficiency with
stoichiometric amount Raney Nickel (3 equiv.). Results were shown in Table 1.
Hydrogenation of stigmasterol with Raney nickel could give a mixture of β-sitosterol and
over reduced saturated stigmastanol. The ratio of these two compounds depends on the
reaction times. However, as shown in Table 1, we found that reduction with Raney
Nickel is not useful as a method to provide pure β-sitosterol (>95%).

Reaction scale

Time

Products
(Stigmasterol : β-sitosterol : stigmastanol)

1mmol

4h

4: 88: 8

1mmol

6h

0 : 89 : 11

1mmol

8h

0 : 85 : 15

1mmol

24h

0 : 61 : 39

Table 1. Hydrogenation of stigmasterol with Raney Nickel

2.2 Stigmasterol hydrogenation with Rieke Nickel
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Rieke metals are a type of highly reactive metal powders, which are prepared by the
methods developed by Reuben D. Rieke.14 The reactivity of Rieke metals results from a
very high surface area and the lack of surface oxides which retard reaction. Highly
reactive Rieke metals are generally prepared by reducing metal salts in ethereal or
hydrocarbon solvent, using alkali metals as reducing agents15 (Equation 2). Typical alkali
metals used in this method are potassium, sodium, and lithium. Among the many metals
that have been generated by this method are Mg, Ca, Ti, Fe, Co, Ni, Cu, Zn, and In.

MXn + nK

M + nKX

Equation 2. Typical method of preparing Rieke Metal

In some cases the reaction is carried out with a catalytic amount (5-10% mole percent) of
an electron carrier such as biphenyl or naphthalene.16 During the reaction performance,
the coprecipitated alkali metal salt is usually not separated from the highly reactive metal,
which is generally used in situ.

A recent study indicates that the selective hydrogenation of multiple carbon-carbon bonds
could be promoted by Rieke Nickel particles. 17 Selective hydrogenations of dienes are
shown in Table 2. In the entry 4, the less hindered alkene in the side chain of (R)limonene was reduced while the trisubstituted alkene in the ring was not affected at all.

Diene

NiCl2-Li-DTBB(cat.)-EtOH
Monoene
THF, rt

8

Entry

Starting diene

T(h)

Product

Yield(%)

1

24

95

2

21

99

3

22

88

4

22

99

Table 2. Selective hydrogenation of diene with Rieke Nickel.17

We investigated the reduction of stigmasterol by Rieke Ni under conditions which could
either allow direct reduction of the alkene by the Rieke Ni or could allow Ni-catalyzed
hydrogenation (Table 3). Superstoichiometric Rieke nickel (3 equiv.) reacted with pure
stigmasterol under an atmosphere of hydrogen at room temperature. However, no βsitosterol was obtained after the attempted reduction. Instead, only the starting material
was recovered.

9

Nickel salt

Reductant

Electron carrier

Result

NiCl2

Li

DTBB (cat.)

No reduction

NiBr2

Li

Naphthalene (cat.)

No reduction

NiBr2

Mg

-

No reduction

NiCl2

Mg

-

No reduction

Table 3. Attempt of Rieke Nickel reduction

2.3 Stigmasterol hydrogenation with platinum dioxide
Platinum dioxide (PtO2), also known as Adams' catalyst, is a commercially available dark
brown powder usually represented as platinum(IV) oxide hydrate, PtO2.H2O. It is widely
used as a precursor to a useful catalyst for hydrogenation and hydrogenolysis in organic
synthesis.18 In the reaction, the platinum dioxide itself is not an active catalyst. But as
soon as this black powder is exposed in hydrogen gas, it will be converted to active black
platinum metal, which is the real reductant and is responsible for reactions.

PtO2 has been widely applied to the selective hydrogenation of dienes in many organic
molecules. It was reported that PtO2 can catalyze the hydrogenation of (-)-perillyl alcohol
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with high selectivity and high yield19 (Scheme 3). The less hindered terminal alkene can
be reduced while the more hindered alkene remains unaffected.
OH

OH

PtO2
H2

Yield 96%

Scheme 3. Selective hydrogenation of (-)-perillyl alcohol with PtO2.21

A suspension containing a mixture of a catalytic amount of PtO2 and pure stigmasterol
was reacted under an atmosphere of hydrogen (balloon) at room temperature to test the
selectivity of hydrogenation. Results are shown in Table 4. We found that hydrogenation
in the presence of PtO2 provides inseparable mixtures of unreacted stigmasterol, βsitosterol, and the saturated stigmastanol. The exception is for prolonged reaction, where
the undesired stigmastanol becomes the only product.

PtO2 %

Solvent

Result (Stigmasterol: β-sitosterol: stigmastanol)

1

MeOH

85:15:0

11

1

EtOH

12:68:20

5

EtOH

0:0:100 (48h)

1

EtOAc

38:38:24

Table 4. Hydrogenation of stigmasterol with PtO2

2.4 Attempts to separate phytosterols by recrystallization.
Recrystallization is a widely used procedure for purifying compounds and removing
impurities, and it has been reported that β-sitosterol can be purified from a mixture of
different sterols via recrystallization procedure 20 (Table 5). Our initial investigations
employed a mixture of phytosterols obtained from our collaborator, Prof. Tim Carr (UNL
Nutrition Sciences) and including mainly β-sitosterol (65%) and α-sitosterol (19%).
Recrystallization of 5g of this mixture in a solvent mixture of 20ml toluene, 15ml acetone
and 2ml water increased the amount of β-sitosterol to approximately 93%, and other
phytosterols were mainly removed.
Before crystallization

After crystallization

β-sitosterol

64.8%

β-sitosterol

93.3%

α-sitosterol

19.0%

α-sitosterol

1.5%

Campesterol

5.5%

Campesterol

4.9%

others

10.7%

others

0.3%

Table 5. Recrystallization of sterols mixture. 22
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However, application of the same recrystallization conditions to 5 g of a sterol mixture
derived from a Raney Nickel hydrogenation (70% β-sitosterol, 8% stigmasterol, and 22%
stigmastanol)

provided a mixture of β-sitosterol (71%), stigmasterol (5%), and

stigmastanol (24%). Similarly, recrystallization of a commercial β-sitosterol sample from
Acros (β-sitosterol 75%, campesterol 10%, and other undefined phytosterols 15%)
provided a mixture of β-sitosterol (87%), campesterol (13%). Overall, our results
demonstrate that it is not practical to obtain pure β-sitosterol from a sterols mixture by
recrystallization.

2.5 Synthetic route to pure β-sitosterol
After experiencing disappointing results with both selective hydrogenation and
recrystallization, I started to research new synthetic routes that could provide pure βsitosterol in amounts sufficient for use in animal feeding studies.

2.5.1 Synthetic route involving McMurry reaction
A retrosynthesis of a new route to sitosterol is shown in Figure 2. It starts with the
reduction of commercially available stigmasterol by Raney Nickel to give a mixture with
β-sitosterol and stigmastanol. Then the Δ5-6 alkene of the β-sitosterol was cleaved via
ozonolysis to the dicarbonyl compound, which would presumably be easily separated
from unreacted stigmastanol by chromatography. Finally, the alkene would be reformed
via the intramolecular McMurry reaction.

13

HO

AcO

O

O

AcO

AcO
Mixtrue with sigmastanol

Figure 2. Retrosynthesis analysis

The McMurry reaction is an organic reaction in which two ketone or aldehyde groups are
reductively dimerized to form an alkene. The reaction uses a reduced titanium reagent
most often prepared from reaction of titanium(III) chloride and a reducing agent, often an
alkali metal.21 This reductive coupling involves two steps. A radical coupling induced by
single electron transfer to the carbonyl groups from alkali metal generates a 1,2-diol as a
titanium alkoxide; a subsequent deoxygenation of the 1,2-diol with low-valent titanium
yields the alkene (Figure 3).

Figure 3. McMurry reaction

Our approach began with commercially available stigmasterol (Scheme 3). Raney nickel
reduction produces an inseparable mixture of β-sitosterol (75%) and stigmastanol (25%)
which was converted to the acetates. The mixture of acetates 10 and 11 was reacted with
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ozone, followed by Zn/AcOH reduction. The dicarbonyl 12 derived from oxidative
cleavage of β-sitosterol acetate was easily separated from the unreacted stigmastanol
acetate. McMurry reaction was applied to the intermediate 12 under the condition of
TiCl3 and K in THF refluxing. However, none of the desired β-sitosterol acetate 10 was
obtained.

Raney Nickel

HO

HO

HO
1

2

3
25%

75%
Ac2O
Pyridine

1) O3, CHCl 3/MeOH = 9/1
2) Zn, H2O/AcOH = 1/9
AcO

O

AcO

AcO
O
12

10

11

75%

25%

yield 44%

AcO
10

Scheme 3. Synthesis of β-sitosterol

It is possible that the failure resulted from the incompatibility of the acetate groups with
the McMurry reagent. We therefore investigated the application of the McMurry reaction
on substrates containing triethylsilyl ethers. As shown in Scheme 4, this approach was
initially modeled on the mixture of triethylsilyl ethers derived from the mixture of
sitosterol and stigmastanol. The mixture was treated with ozone, and the crude products

15

were reduced with PPh3 reduction to generate an easily separated mixture of dicarbonyl
compound 14 and the unreacted stigmastanol ether. It should be noted that a phosphine
reduction was employed because the Zn/AcOH reduction employed in the previous
example was anticipated to be incompatible with the triethylsilyl ether. A pure sample of
14 was treated with typical McMurry reaction condition (TiCl3 and K). However, once
again, the reaction failed to generate the desired sitosterol skeleton (13).

TESCl, iPrNH2
DMAP, Et2O
HO

TESO
2
75% purity

13
75% purity

1) O3, CHCl3/MeOH = 9/1
2) PPh3, Et2O

TESO
TESO
13

O

O
14

Scheme 4. Reaction attempts with TES protecting group

2.5.2 Synthetic route involving epoxide intermediate
We ultimately developed a successful synthetic route to pure β-sitosterol based on a
sequence involving selective epoxidation of ∆5-6 alkene, hydrogenation of the sidechain
alkene, and deoxygenation of the epoxide (Figure 4).
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Figure 4. Retrosynthesis analysis

Our approach was inspired by a recent study22 of epoxidation of cycloolefins by the tBuOH copper-permanganate system. This study included an example of the selective
oxidation of stigmasteryl acetate at ∆5-6 alkene, producing a mixture of 5α,6α-epoxide
and 5β,6β-epoxide with the ratio β/α= 6/1 (Figure 5).

Cu(MnO4)2
tBuOH-CH 2Cl 2 (3:1)
AcO
AcO

O
 epoxide

AcO

O
 epoxide

Figure 5. Selective oxidation of stigmasterol acetate via Cu(MnO4)2

However, if we were going to use an epoxide as an alkene protecting group, we would
also require a mild method of regenerating the alkene. Although a number of reagents
have been reported for reductive deoxygenation of epoxides,23 most are relatively harsh.
We became interested in a report describing the deoxygenation of epoxides at room
temperature using aluminium triiodide.24
iodoalcohol intermediate (Figure 6).

The deoxygenation is thought to involve an
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R1

O

R3

OH

R1

AlI3

R3

R1

R3

I2
R2

R4

R2

R4

I

R2

R4

Figure 6. Reduction of epoxide with AlI3

Based on the above reports, we developed a new synthesis of β-sitosterol as illustrated in
Scheme 5. Cu(MnO4)2 was prepared in situ by reaction of KMnO4 and CuSO4. Selective
epoxidation of the Δ5-6 alkene of stigmasterol acetate 15 with Cu(MnO4)2 formed a 6:1
mixture of the 5β,6β-epoxide 16a and 5α,6α-epoxides 16b. The ratio of two isomers was
determined by NMR (Figure 7). Hydrogenation of the mixture of 16a and 16b over Pd/C
cleanly furnished a 1:6 mixture of stigmastanol epoxides 17a and 17b. Then
deoxygenation of the saturated epoxides with AlI3 proceeded rapidly to furnish a good
yield of β-sitosteryl acetate 10. Saponification afforded pure β-sitosterol 2, with mp 134135 °C and [α]D = - 37, which matched very closely with literature values.26

HO

Ac2O

Cu(MnO4) 2

Pyridine

tBuOH-CH2Cl2 (3/1)

AcO

AcO

1

O

15

AcO

O
16b

16a

Pd/C
H2 balloon

AlI 3

K 2CO 3

AcO
HO

AcO
2

10

O
17a

AcO

O
17b

18

Scheme 5. Synthesis of β-sitosterol

Figure 7. 1H NMR spectra of 5α,6α and 5β,6β-epoxide of stigmasteryl acetate

I also investigated a variant of this route based upon epoxidation with the commercially
available peracid m-chloroperbenzoic acid (mCPBA). The use of this oxidant also
resulted in regioselective oxidation of the ∆5-6 alkene, but now produced a 2.6:1 mixture
of stigmasterol oxides favoring the α-isomer 16a. Hydrogenation proceeded uneventfully
to furnish the corresponding mixture of sitosterol oxides 17a and 17b.

However,

attempted deoxygenation under the same conditions as employed earlier (AlI3, 10 min,
CH3CN/CH2Cl2) now furnished only 33% of β-sitosterol acetate 10, accompanied by a
significant amount (estimated > 60% by mass) of a more polar product which yellowed
immediately upon exposure to room light. The formation of the byproduct could be
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avoided almost completely by allowing the deoxygenation to proceed for 40 min.
Alternatively, the byproduct could be converted to β-sitosterol acetate 10 by treatment
with additional AlI3. The results suggest that the deoxygenation of the α- and β-epoxides
proceeds at very different rates, with the 5α, 6α-diastereomer 16a reacting via the
intermediacy of a semistable iodohydrin. I therefore focused on the use of the CuMnO4
system for my studies.

The ability to protect the ∆5,6-alkene of stigmasterol also suggested a facile means of
preparing

other

sidechain-modified

phytosterols.

Phytosterols

with

sidechain-

modification have been important in studying phytosterol metabolism in human body.25
Although methods have been reported for preparation of sidechain-modified phytosterol,
26

these synthetic routes are not efficient. Since the epoxide intermediates 16a and 16b

are quite stable, we reasoned that they would be easily converted to the corresponding
aldehydes via ozonolysis, allowing introduction of new side chains via Wittig or Julia
chemistry (Figure 8).

Figure 8. Strategy to prepare sidechain-modified phytosterols

As an example of this methodology, we chose to convert stigmasterol to campesterol,
using a Julia olefination for introduction of the campesterol sidechain. The necessary
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sulfone (22) was prepared as a single enantiomer as illustrated in scheme 6.27 Alkylation
of (S, S)-pseudoephedrine isovalerylamide with 3-methylbut-3-enyl triflate led to the
formation of hydroxyamide 19. Reduction of 19 with lithium aminotrihydroborate (LAB)
gave the (S)-2,3-dimethylbutanol 20 with 90% ee. Then the alcohol 20 could be
converted to sulfide 21 through Mitsunobu reaction. Oxidation of 21 with molybdenum
salt afforded sulfone 22.

NH

O

O

NEt3

LDA

OH
O

N

MeI

N

+

OH

OH

19

18

Cl
S

O

SH
N

LAB
THF

HO

DIAD, PPh3
THF

S

S

N

20

(NH4 )6Mo7O 24 .4H 2O

S

S

H2O 2, EtOH

N

O

21

22

Scheme 6. Preparation of enantiomerically pure sulfone intermediate.

Ozonolysis of the mixture of 16a/16b furnished an approximately 1:6 mixture of
aldehydes 23a and 23b. Julia-Kocienski olefination, using the sulfone 22, furnished
exclusively the alkene corresponding to the monoepoxide of the Z-isomer of
crinosterol.28 The Z-stereochemistry was assigned from the 10.6 Hz coupling constant for
H22-H23. Finally, hydrogenation, followed by deoxygenation of the epoxide as before,
furnished campesterol acetate 26 (Scheme 7).
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Scheme 7. Synthesis of campesterol acetate

The selective formation of Z-alkenes is unusual in Julia-Kocienski couplings, since most
of time this reaction produces E-alkenes as the final product. I therefore investigated the
olefination of 16a,b with a model isobutyl sulfone 27 derived from isobutyl alcohol
(Figure 8). This reaction also selectively furnished the Z-alkene; the lower selectivity (2:1)
compared with that observed for the synthesis of 24a,b may reflect the reduced degree of
steric encumbrance in this model system. The ability to readily prepare Z-isomers of
phytosterols opens the door to a number of steroid analogs not available from synthetic
routes based upon Claisen rearrangements of C22 allylic alcohols.29

22

Figure 8. Generality of Z-selective olefination

Overall, the formation of beta-sitosterol has been achieved in 52% overall yield from
commercially available stigmasterol using relatively simple chemistry and via easily
purified intermediates. The core strategy, protection of the ∆5-6 alkene as an epoxide,
holds potential for synthesis of other phytosterols, including Z-isomers of existing
phytosterols.

3. Experimental

General Experimental Conditions
All reagents and solvents were used as supplied commercially, except CH2Cl2 and THF,
which were distilled from CaH2, and Na/benzophenone, respectively. All reactions were
conducted under an atmosphere of N2 except where noted; “RBF” indicates round-bottom
flask. Thin layer chromatography (TLC) was performed on 0.25 mm hard-layer silica G
plates. Developed TLC plates were visualized with a hand-held UV lamp or by staining:
1% ceric sulfate and 10% ammonium molybdate in 10% H2SO4 (general stain, after
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charring);

1%

N,N’-dimethyl-p-phenylenediamine

solution

in

1:20:100

acetic

acid/water/methanol (specific for peroxides); Melting points are uncorrected. Unless
noted, NMR spectra were acquired at 400 MHz (1H) or 100 MHz (13C) in CDCl3. IR
spectra were recorded as neat films on a ZrSe crystal with selected absorbances reported
in cm-1. Mass spectroscopy was conducted at the Nebraska Center for Mass Spectrometry.

Raney Nickel preparation
A solution of NaOH (12.6 g, 0.315 mol) in distilled water (50 ml) is cooled in an ice bath
to 10℃. Nickel-Aluminum alloy (10 g) was added to the stirred solution in small portion
and at a rate to prevent the temperature from rising above 25℃.When the entire alloy has
been added, the reaction mixture is allowed to heat until there is no gas from the solution.
Stirring was stopped and the reaction mixture was allowed to settle. After the aqueous
supernatant was decanted. The residue was washed with distilled water for 20 times until
it is neutral, and then the solid was washed with EtOH for 3 times and stored in EtOH for
future use.

Raney Nickel reduction
To the stigmasterol (4.2g, 10mmol) in EtOAc 400 ml, Raney Nickel (5g) was added.
Then the reaction mixture was stirred in room temperature under the H2 balloon at 1 atm
overnight. The Raney Nickel was filtered through Celite, and the organic solvent was
removed under vacuo to afford the crude product, which was analyzed by GC-MS.
GC-MS conditions: injector 270℃, FID detector 300℃, oven 270℃ for 1min, ramp at 15℃
/min to 300℃ as final temperature.
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Stigmasterol acetate (15)

AcO
15

Stigmasterol acetate was prepared as a white solid (97%, mp 138-140℃) by a variant of
the procedure of Wang.30 Other physical data were identical to the literature.31

5α,6α- and 5β,6β-epoxides of stigmasterol acetate (16a, 16b)

AcO

O
16a -isomer
16b -isomer

A mixture of KMnO4 (10 g, 60 mmol) and CuSO4•5H2O (5 g, 20 mmol) was ground to a
fine powder in a mortar and pestle. Water 0.5 mL was added, and the slightly wet mixture
was transferred to the reaction flask. To the stirred suspension of this mixture in 25 mL
CH2Cl2, compound 2 (2.12 g, 5 mmol) was added, followed by t-BuOH 2.5 mL. Reaction
mixture reflux for 1 hour and then cool down. The reaction mixture was filtered through a
silica pad, washed with ether. After evaporation the solvent, crude solid was
recrystallized from methanol to give a white solid 1.59 g, overall yield 75%. NMR data
indicates the product was a 1:6 mixture of epoxides 16a and 16b.26
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5α,6α- and 5β,6β-epoxy sitosterol acetate (17a, 17b)

AcO

O
17a -isomer
17b -isomer

A 1:6 mixture of 17a and 17b (1.35 g, 3.0 mmol) was dissolved in EtOAc 150 mL. 10%
Pd/C (0.32 g) was added, and reaction mixture stirred at room temperature under an
atmosphere of H2 balloon for 12 hours. The reaction mixture was filtered through a Celite
pad, and evaporated to a white solid (1.28 g, 96%) as a 1:6 mixture of epoxides 17a and
17b.32

Sitosterol acetate (10)

AcO
10

The mixture of epoxides 17a and 17b (470 mg, 1.0 mmol) was dissolved in 2:1
CH3CN/CH2Cl2 30 mL. Aluminum triiodide was added (610 mg, 1.5 mmol) and the
resulting mixture was stirred at room temperature for 10 minutes. The reaction was
quenched with aq. 10% Na2S2O3 100 mL and the resulting mixture was extracted with
CH2Cl2 (3 x 100 mL). The combined organic layers were dried over Na2SO4, and the
residue from the concentrated filtrate was purified by flash chromatography
(hexane/EtOAc, 95:5) to give 360 mg (80%) of sitosterol acetate 10 as a white solid. Mp
111-112℃, [α]D = -34.5 (CHCl3). Other physical data were identical to the literature.26
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β-Sitosterol (2)

OH
2

Sitolsterol acetate 10 (240 mg, 0.47 mmol) was dissolved in a mixture of 15 mL CH3OH
and 15 mL CH2Cl2, K2CO3 (140 mg, 1 mmol) was added. Reaction mixture stirred at
room temperature for 12 hours. Remove solvent under vacuum. The residue was
extracted with 30 mL CH2Cl2 and 30 mL water. Combined organic layer dried over
Na2SO4, filtered and evaporated. Crude solid was purified through flash chromatography
(hexane/EtOAc, 80:20) to to give white solid 220 mg, yield 93%. Mp 134-135℃, [α]D = 37 (CHCl3). Physical data was identical to the literature.26

(S)-2,3-Dimethylbutan-1-ol (20)

HO
20

(S)-2,3-Dimethylbutan-1-ol 20 was prepared as a colorless liquid, overall yield 60%, [α]D
= 4.4 (CHCl3), by the procedure of Tietze from (+)-(1S,2S)-Pseudoephedrine. Other
physical data were identical to literature values.29

(S)-2-(2,3-dimethylbutylthio)benzothiazole (21)
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S

S

N
21

To a mixture of 20 (102 mg, 1 mmol), 2-mercaptobenzothiazole (183 mg, 1.1 mmol) and
PPh3 (288 mg, 1.1 mmol) in freshly distilled THF (4 mL) was added DIAD (0.21 mL, 1.1
mmol) dropwise at 0 ℃ under argon. After being stirred for 3 hours at the same
temperature, the reaction was quenched by water. The aqueous layer was extracted with
EtOAc (10mL x 3 ). The combined organic layer was dried over anhydrous Na2SO4,
filtered and concentrated in vacuo. Flash chromatography (hexane/EtOAc, 99:1) afforded
thioether 21 (228 mg, 91%) as a light yellow oil. [α]D = 42.3 (CHCl3); IR 2957, 1455,
1426, 1057, 991, 752 cm-1; 1H NMR (400 MHz, CDCl3): δ7.89 (d, J= 8.06 Hz, 1H),
7.75 (d, J= 8.06 Hz , 1H), 7.42 (t, J= 7.19 Hz, 1H), 7.29 (t, J= 7.19, 1H Hz), 3.50 (dd,
J=12.66 Hz, 4.84 Hz, 1H), 3.18 (dd, J= 12.65Hz, 8.18 Hz, 1H), 1.88-1.77 (m, 2H), 1.04
(d, J=6.67 Hz, 3H), 0.99 (d, J= 6.56 Hz, 3H), 0.94 (d, J= 6.56 Hz, 3H); 13C NMR (100Hz,
CDCl3): δ167.75, 153.38, 135.15, 125.99, 124.08, 121.44, 120.91, 38.87, 38.78, 31.62,
20.37, 17.96, 15.29; HRMS (m/z) [M-H]+ calcd for C13H18NS2+: 252.0881, found:
252.0875

(S)-2-(2,3-dimethylbutylsulfonyl)benzothiazole (22)
O
S

S

N

O
22

A solution of 21 (183 mg, 0.73 mmol) in EtOH (10 mL) was oxidized with ammonium
heptamolybdate tetrahydrate (1.8 g, 1.46 mmol) and 30% H2O2 (2.5 mL, 21.9 mmol) at 0℃
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for 2 hours. The mixture was extracted with EtOAc (10 mL x 3). The combined organic
extracts were washed with brine (10 mL x 3), dried over anhydrous Na2SO4, filtered and
concentrated in vacuo. Flash chromatography (hexane/ EtOAc, 90:10) afforded sulfone
22 (177mg, 86%) as a pale yellow oil. [α]D = 15.5 (CHCl3); IR 2961, 1470, 1324, 1140,
1085, 758 cm-1; 1H NMR (400 MHz, CDCl3): δ8.23 (d, J= 7.92, 1H), 8.03 (d, J= 7.92,
1H), 7.68-7.59 (m, 2H), 3.59(dd, J= 14.36, 3.54Hz, 1H), 3.31(dd, J= 14.11, 8.95Hz, 1H),
2.29-2.19(m, 1H), 1.82-1.73(m, 1H), 1.10(d, J= 6.89Hz, 3H), 0.89(d, J= 6.80Hz, 3H),
0.85(d, J= 6.89Hz, 3H);

13

C NMR (100Hz, CDCl3): δ166.66, 152.70, 136.74, 128.00,

127.67, 125.43, 122.38, 58.83, 38.68, 32.47, 19.23, 17.89, 15.93; HRMS (m/z) [M-H]+
calcd for C13H18NO2S2+: 284.0779, found: 284.0778

5α,6α-and 5β,6β-epoxides of (3β,20R)-3-acetyloxy-pregnane-20-carboxaldehyde (23a,
23b)
O

AcO

O
23a -isomer
23b -isomer

A solution of 16a, 16b (100 mg, 0.21 mmol) in 10 mL of 50/50 CH2Cl2/MeOH was
ozonolyzed at -78℃ for 5 minutes, then solvent was removed under vacuum. Residue
was dissolved in 10 mL of 10/90 H2O/AcOH, Zinc powder (55 mg, 0.84 mmol) was
added, and reaction mixture stirred for 2 hours at room temperature. 50 mL CH2Cl2 was
added. Organic layer was washed with water (25 mL x 3), then dried over anhydrous
Na2SO4, filtered and concentrated in vacuo. Flash chromatography (hexane/ EtOAc,
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90:10) afforded white solid (81mg, 99%) as 1:6 mixture of epoxides 23a and 23b. IR:
2950, 1727, 1367, 1262, 1238, 1042, 783cm-1; 1H NMR (400 MHz, CDCl3): δ 9.57 (d,
J= 3.29 Hz, 0.76H, b), 9.55 (d, J= 3.3 Hz, 0.16H, a), 4.99-4.91 (m, 0.14H, a), 4.814.73(m, 0.87H, b), 3.09(d, J= 2.23Hz, 0.88H, b), 2.90 (d, J= 4.18Hz, 0.13H, a), 2.382.31(m, 1H), 2.13-1.82(m, 9H), 1.54-0.89(m, 20H), 0.7(s, 3H);

13

C NMR (100Hz,

CDCl3): δ204.95, 170.52, 71.25, 63.41, 62.48, 55.39, 51.05, 50.93, 49.42, 42.89, 39.43,
37.95, 36.67, 35.06, 32.41, 29.74, 27.17, 26.97, 24.54, 21.84, 21.30, 17.03, 13.40, 12.11;
HRMS (m/z) [M-Li]+ calcd for C24H36LiO4+: 395.2774, found: 395.2778

5α,6α- and 5β,6β-epoxides of (3S,10S,13R,17R)-17-((2R,5S,Z)-5,6-dimethylhept-3-en-2yl)-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate (24a, 24b)

AcO

O
24a -isomer
24b -isomer

To sulfone 22 (62 mg, 0.22 mmol) in 5 mL THF was added LiHMDS (0.22mL, 1M in
THF, 0.22 mmol) dropwise at -78℃ and stirred for 1 hour. Aldehyde 23a and 23b (85
mg, 0.22 mmol) was added in 5 mL THF. Stirring was continued for 1 hour, and reaction
was gradually warmed to room temperature. The reaction was quenched by 15 mL water.
The aqueous layer was extracted with EtOAc (10 mL x 3), then dried over anhydrous
Na2SO4, filtered and concentrated in vacuo. Flash chromatography (hexane/ EtOAc, 95:5)
afforded white solid (90 mg, 90%) as 1:16 mixture of epoxides 24a and 24b. IR: 2950,
2867, 1743, 1368, 1037, 764cm-1; 1H NMR (400 MHz, CDCl3): δ5.02(dd, J= 10.96,
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9.88 Hz, 2H), 4.83-4.73(m, 1H), 3.09(d, J=2 Hz, 0.95H, b), 2.91(d, J=4.4 Hz, 0.06, a),
2.43-2.33(m, 1H), 2.21-1.80(m, 9H), 1.68-0.83(m, 31H), 0.69(s, 3H);

13

C NMR (100Hz,

CDCl3): δ170.56, 135.13, 131.22, 71.34, 63.58, 62.52, 56.27, 56.02, 51.02, 42.18, 39.72,
38.32, 38.01, 36.68, 35.04, 34.48, 33.35, 32.43, 29.74, 28.32, 27.20, 24.15, 21.92, 21.34,
20.55, 20.36, 19.94, 18.63, 17.06, 12.06; HRMS (m/z) [M-H]+ calcd for C30H49O3+:
457.3682, found: 457.3668

5α,6α-and 5β,6β-epoxides of campesterol acetate (25a, 25b)

AcO

O
25a -isomer
25b -isomer

The mixture of epoxides 24a and 24b (30mg, 0.07 mmol) was dissolved in 5mL EtOAc.
10% Pd/C (7 mg) was added, and reaction mixture stirred at room temperature under an
atomphere of H2 balloon for 12 hours. The reaction mixture was filtered through a Celite
pad, and evaporated to a white solid (28mg, 94%) as 1:9 mixture of epoxides 25a and
25b. IR: 2953, 2867, 1729, 1367, 1263, 1043, 784cm-1; 1H NMR (300 MHz, CDCl3): δ
5.01-4.93(m, 0.15H, a), 4.83-4.73(m, 0.96H, b), 3.09(d, J=2.07 Hz, 0.9H, b), 2.90(d, J=
4.35 Hz, 0.1H, a), 2.12-1.8(m, 8H), 1.58-0.77(m, 37H), 0.65(s, 3H);

13

C NMR (75Hz,

CDCl3): δ170.54, 71.34, 63.58, 62.51, 56.19, 56.14, 50.97, 42.28, 39.78, 38.81, 38.01,
36.66, 35.82, 35.03, 33.65, 32.47, 32.41, 30.26, 29.73, 28.14, 27.21, 24.18, 21.92, 21.31,
20.19, 18.66, 18.24, 17.03, 15.37, 11.76; HRMS (m/z) [M-H]+ calcd for C30H51O3+:
459.3838, found: 459.3820
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Campesterol acetate (26)

AcO

26

The mixture of epoxides 25a and 25b (28 mg, 0.06 mmol) was dissolved in 2:1
CH3CN/CH2Cl2 (3 mL). Aluminum triiodide was added (37 mg, 0.09 mmol) and the
resulting mixture was stirred at room temperature for 30 minutes. The reaction was
quenched with aq. 10% Na2S2O3 (10 ml) and the resulting mixture was extracted with
CH2Cl2 (3 x 10 mL). The combined organic layers were dried over Na2SO4, and the
residue from the concentrated filtrate was purified by flash chromatography
(hexane/EtOAc, 95:5) to give 24mg (91%) of campesterol acetate 26 as a white solid. Mp
130-131℃, [α]D = -32 (CHCl3); IR 2954, 1730, 1367, 1247, 1037, 735cm-1; 1H NMR
(400 MHz, CDCl3): δ5.39(d, J=4.77Hz, 1H), 4.66-4.58(m, 1H), 2.33(d, J=7.87Hz, 2H),
2.05(s, 3H), 1.90-1.84(m, 2H), 1.59-0.78(m, 38H), 0.68(s, 3H);

13

C NMR (100Hz,

CDCl3): δ170.56, 139.66, 122.66, 73.99, 56.69, 56.08, 50.02, 42.31, 39.73, 38.84, 38.12,
36.99, 36.59, 35.90, 33.70, 32.43, 31.90, 31.86, 30.27, 28.24, 27.78, 24.29, 21.46, 21.03,
20.22, 19.32, 18.70, 18.26; HRMS (m/z) [M-Na]+ calcd for C30H51O2Na+: 465.3709,
found: 465.3703

2-[(2-Methylpropyl)sulfonyl] benzothiazole (27)
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27
Compound 27 was prepared using the same procedure with benzothiazole 22. Mp 4445℃. Other physical data were identical to the literature.33

Model reaction of 27 with 16a,b

The reaction procedure was the same with the formation of 24a,b. Yield (88%). IR: 2953,
2869, 1740, 1355, 1053cm-1; 1H NMR (400 MHz, CDCl3): δ5.28(dd, J=15.3, 6.4 Hz,
0.35H, trans-alkene), 5.16 (dd, J=15.3, 8.1Hz, 0.36H, trans-alkene), 5.02(dd, J=8.15, 2.61,
0.63H, cis-alkene), 4.98(dd, J=8.14, 2.94Hz, 0.62H, cis-alkene), 4.81-4.72(m, 1H),
3.09(d, J=2 Hz, 0.95H, β-isomer), 2.91(d, J=4.4 Hz, 0.06, α-isomer), 2.66-2.54(m, 1H),
2.48-2.37(m, 1H), 2.23-1.67(m, 9H), 1.58-0.89(m, 29H), 0.69(s, 2H), 0.66(s, 1H);

13

C

NMR (100Hz, CDCl3): δ170.55, 134.91, 134.24, 133.97, 133.49, 71.33, 63.66, 62.52,
58.26, 56.04, 51.01, 42.19, 39.82, 39.71, 38.00, 36.67, 36.05, 34.52, 32.44, 30.92, 29.73,
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28.34, 28.27, 27.20, 26.80, 24.16, 23.58, 23.14, 22.75, 21.91, 21.32, 21.10, 17.05, 12.07,
11.97; HRMS (m/z) [M-Na]+ calcd for C28H44O3Na+: 451.3188, found: 451.3194
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Chapter 2. Study of phytosterol ester and phytosterol ether metabolism mechanism
(Portions of the material included in this chapter have been published. Brown, A. W.,
Hang, J. Dussault, P. H., Carr, T. P. Phytosterol ester constituents affect micellar
cholesterol solubility in model bile, Lipids 2010, 45, 855; Brown, A. W., Hang, J.,
Dussault, P. H., Carr, T. Sterol and stanol substrate specificity of pancreatic cholesterol
ester lipase, J. Nutr. Biochem. 2010, 21, 736)

2.1 Introduction
In the United States, cardiovascular disease is the leading cause of death over the last two
decades, and now accounts for over 25% of all deaths each year.34 These cardiovascular
diseases are often linked with chronic kidney disease and hypercholesterolaemia,
especially the high concentration of cholesterol in low-density lipoprotein (LDL). 35 A
lipoprotein is a protein that exists as an aggregate or complex including a substantial
number of fats and lipids. Lipoproteins transport fats and lipids in the bloodstream,
providing a means for fats to move through a water-rich environment. The five major
classes of proteins are classified according to their density (Table 1). Low-density
lipoprotein (LDL) has the highest concentration of cholesterol (50%) of any lipoprotein
and increased levels of LDL have been associated with increased risk of cardiovascular
disease. Therefore, the goal in many pharmaceutical and nutraceutical therapies is to
decrease LDL concentration in the human body. One of the most successful nutraceutical
approaches to reducing LDL levels is through consumption of free plant sterol or sterol
esters.36
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4

1.019-1.063

LDL

25
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8

1.006-1.019

IDL

18

29

22
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0.95-1.006

VLDL

10

22

18

50

<0.95

Chylomicron

<2

8

7

84

s
Table 1. Classification of lipoprotein.37

The mechanism by which phytosterol consumption decreases LDL has not been clarified
yet. A recent study suggested that phytosterols could decrease the incorporation of
cholesterol into intestinal micelles, thus reducing cholesterol absorption and increasing
excretion of cholesterol.38 Besides free phytosterols, phytosterol esters are found to show
similar ability to decrease the concentration of cholesterol. As dietary additives, both free
phytosterols and phytosterol esters are shown to be effective in displacing cholesterol.
However, using in-vitro models, only free phytosterols have the same ability. 39 This
observation suggests that the phytosterol esters must be hydrolyzed in the digestive tract
to generate phytosterols which can be subsequently micellarized and absorbed. The
enzyme pancreatic cholesterol esterase (PCE) is the likely agent responsible for the
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hydrolysis of phytosterol esters. 40 PCE, an ester hydrolase with broad substrate
specificity,41 has showed important functions in the intestine, including controlling the
bioavailability of cholesterol from dietary cholesterol esters and contributing to
incorporation of cholesterol into mixed micelles.42

Collaborating with Dr. Carr research group (UNL Department of Nutrition and Health
Sciences), we studied the mechanisms why consumption of phytosterols and phytosterol
esters could decrease the LDL concentration, and examined the effect of simulated
phytosterol esters hydrolysis products concentration on micellar cholesterol solubility in a
model bile system. Our role in this collaboration was the preparation of phytosterol esters
and ethers.

2.2 Results and discussion
Preparation of phytosterol esters
As illustrated in scheme 1, phytosterol esters were prepared via the reaction between free
sterol and acid chloride, respectively. Each phytosterol ester was prepared on a 120 gram
scale.
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Scheme 1. Synthesis of phytosterol esters

Preparation of phytosterol octadecyl ether
The Carr group had formulated a hypothesis that the free phyotosterol, generated upon
hydrolysis of phytosterol esters within the intestine, is able to displace cholesterol from
micelles. In order to demonstrate that the micellar effect results from the free sterols and
not the esters, we were interested in molecules that were structural analogs of the
phytosterol esters but would not undergo hydrolysis by PCE or similar enzymes. We
therefore prepared octadecyl ethers of the phytosterol on 120 gram scale (scheme 2).
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Scheme 2. Synthesis of phytosterol octadecyl ether.

While there are numerous methods for making short-chain ethers of sterols, particularly
cholesterol, 43,44 there are few reports describing synthesis of long-chain ethers. Zhang
reported the alkylation of cholesterol in the condition of dodecyl bromide, sodium
hydride and THF solvent afforded the cholesteryl dodecyl ether with 29% yield in the 5
gram scale.45 However, it is difficulty to apply this method to 120 gram scale preparation,
which could not use column chromatography as the purification tool. In order to
overcome this problem, I screened different reaction conditions for phytosterol octadecyl
ether synthesis in preparative reaction (Table 1). In the solo THF solvent, this reaction
requires as much as 8 eq. alkyl iodide to complete starting sterol, with an isolation yield
about 56% (Entry 1 and 2). If 18-crown-6 was added to reaction mixture to help the
alkoxy anion more soluble in THF solvent, this reaction will furnish at 50% conversion
of sterol (Entry 3). However, if the mixture solvent system THF/DMF(3/1) was used, the
conversion and isolation yield will increase significantly (Entry 4, 5, and 6). Considering
the atomic efficiency and affordable isolation yield, reaction ratio of 2 eq. alkyl iodide, 2
eq. sodium hydride was used to prepare phytosterol octadecyl ether, which could be
purified by recrystallization from hot ethyl acetate.
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Entry

phytosterol (eq.)

C18H37I (eq.)

NaH (eq.)

Solvent

Yield

1

1

2

2

THF

<20% form TLC

2

1

8

8

THF

56% (10g scale)

3

1 (with 1eq. 18- 2

2

THF

Conversion 50%

crown-6)

from TLC

4

1

4

4

THF/DMF(3/1)

60% (10g scale)

5

1

4

8

THF/DMF(3/1)

57% (10g scale)

6

1

2

2

THF/DMF(3/1)

45% (50g scale)

Table 1. Reaction conditions screen for synthesis of phytosterol octadecyl ether.

Summary of investigations of: 1) influence of the phytosterols and phytosterol esters
on micellarization of cholesterol; and, 2) the role of phytosterol ester or ether
structure on the acctivity of pancreatic cholesterol esterase. This part of research was
performed by Andrew Brown (PhD, 2011) in the research group of Dr. Tim Carr in the
UNL Department of Nutrition and Health Sciences.

1) The presence of an equal amount of stigmasterol, β-sitosterol or stigmastanol
decreases the cholesterol solubility in micelles by approximately 50%. The results
indicate stigmasterol is more effective than β-sitosterol and stigmastanol in displacing
cholesterol. Andrew Brown also compared different fatty acids to simulate the
byproducts of ester hydrolysis of fatty esters. Unsaturated fatty acids increased the
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micelle solubility of sterols compared with saturated fatty acids or no fatty acids, and the
result does not depend on the size of model micelles. Finally, an in vivo study indicates
that the combination of stigmasterol and saturated fatty acids is the most effective for
lowing cholesterol micelle solubility. They also demonstrated that in vivo models, both
free and esterified esters could lower the cholesterol concentration in micelles, which
confirms the sterol esters must be firstly hydrolyzed to impart the cholesterol-lowering
properties. The detailed results are reported in Brown, A. W., Hang, J., Dussault, P. H.,
Carr, T. J. Nutr. Biochem. 2010, 21, 736.

2) Pancreatic cholesterol esterase hydrolyzes palmitate, oleate and stearate esters of
cholesterol, stigmasterol, stigmastanol and β-sitosterol. The rate of hydrolysis was
dependent on both the sterol and the fatty acid moieties in the following order:
cholesterol > β-sitosterol = stigmasterol >stigmastanol; oleate > palmitate = stearate. The
addition of free phytosterols to the system did not change hydrolytic activity of
pancreatic cholesterol esterase, while addition of palmitate, oleate or stearate increased
activity. The detailed results are reported in: Brown, A. W., Hang, J. Dussault, P. H., Carr,
T. P. Lipids 2010, 45, 855

2.3 Experimental Section
Stigmasterol (95%) was purchased from TCI America. β-Sitosterol (75%) was purchased
from ACROS Organics. Stigmastanol (95%) was prepared via hydrogenation of
stigmasterol.46
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Synthesis of phytosterol esters (illustrated for β-sitosteryl palmitate):
Palmitoyl chloride (30 g, 0.11 mol) were added dropwise to a stirred mixture of βsitosterol (30 g, 0.072mol) and dimethylaminopyridine (2.4 g, 0.021 mol) in 100 ml of
dry pyridine and 400 ml of dry chloroform at room temperature, and stirred overnight.
The reaction was diluted with 1L of water. The resulting suspension was acidified to a pH
of 3–4 with 3 M HCl and subsequently extracted with three washes of 500 ml of
dichloromethane. The combined organic layers were dried over sodium sulfate and
solvent was removed under reduced pressure. The residue was recrystallized from hot
ethyl acetate to furnish sitosteryl palmitate (44 g, 88% yield) as a white solid (mp 79–
80°C). Other physical data were identical to literature reports. 47 Analysis by 1H NMR
suggested the sitosteryl palmitate was 92% pure and contained approximately 8% of a
mixture of stigmasteryl and stigmastanyl palmitates. The experiment was performed in
three batches to collect 120 g phytosterol ester.

Other phytosterol esters were prepared with the similar procedure (Table 2).
Phytosterol ester

Yield %

Stigmasterol palmitate

92

β-Sitosterol palmitate

89

Stigmastanol palmitate

93

Stigmasterol stearate

94

β-Sitosterol stearate

88

42

Stigmastanol stearate

90

Stigmasterol oleate

83

β-Sitosterol oleate

85

Stigmastanol oleate

79

Table 2. Preparation of phytosterol esters.

Synthesis of phytosterol octadecyl ether
To a commercial mixture of phytosterol (50 g, 0.10 mol; contains β-sitosterol 75%,
campesterol 10%), tetrahydrofuran (500 ml) and dimethylformamide (160 ml), sodium
hydride (11 g, 0.25 mol; sodium hydride 60% dispersion in mineral oil was washed with
hexane for three times) was added slowly at 0°C. After no evolution of gas, the reaction
mixture then refluxed for 1 hour. The reaction was allowed to cool to r.t., and octadecyl
iodide (91 g, 0.24 mol) was added. Then reaction mixture was refluxed for 12 hours.
Tetrahydrofuran was removed under vacuum, and the residue was extracted with ether
(200 ml) three times. The combined ether layer was dried over Na2SO4, filtered, and
concentrated to afford crude product. Recrystallization from hot ethyl acetate furnished
phytosterol octadecyl ether, mp 67- 68 °C (30 g, 45%). This experiment was performed
in four batches to collect 120 g phytosterol octadecyl ether.
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Chapter 3
A new peroxide fragment: generation of singlet oxygen from 1,1-dihydroperoxide
and its derivatives
(Portions of the material included in this chapter have been published. Jiliang Hang,
Prasanta Ghorai, Solaire A. Finkenstaedt-Quinn, Ilhan Findik, Emily Sliz, Keith
T.Kuwata, and Patrick H. Dussault; Generation of Singlet Oxygen from Fragmentation of
Monoactivated 1,1-Dihydroperoxides; J. Org. Chem, 2012, 77, 1233.)

We reported that monoactivated derivatives of 1,1-dihydroperoxides undergo a
previously unobserved fragmentation to generate high yields of singlet molecular oxygen
(1O2).

3.1 Introduction
Oxygen, represented by the symbol O, is an element with atomic number 8 and molecular
weight 16. It is one of the most abundant elements on the earth and comprises about 21%
in the atmosphere, 89% in seawater, 47% in Earth’s crust and 60% in the human body. In
nature, one simplest but most important substance that contains oxygen element is
oxygen gas (O2), which is composed by two oxygen atoms. This colorless, odorless, and
tasteless gas plays an important role for almost all living organisms, it is essential for
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energy generation and respiration. Nowadays, oxygen has been widely applied in many
different industries, including steel manufacturing, chemical processing, metal fabrication,
petroleum refining, and etc.48, 49

The

electronic

configuration

for

ground

state

oxygen

is

(1σs)2(1σs*)2(2σs)2(2σs*)2(2σp)2(2πx)2(2πy)2(2πx*)1(2πy*)1. This ground state is triplet (3Σg-)
and paramagnetic because of two parallel electronic spins. Except for the two electrons at
the antibonding 2πx*and 2πy*orbitals, all other molecular orbitals are fully occupied. For
the excited state of oxygen, there are two different singlet states, 1Δg and 1Σg+ (Figure 1).

Figure 1. Electronic configurations of oxygen molecular in ground and excited states.
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The 1Δg state is 22 kcal/mole higher in energy compared with the ground state. The
radiative lifetime is 45 minutes at very low gas pressure and 10-6 – 10-3 s in solutions. The
1

Σg+ excited state, is 37 kcal/mole above the ground state and the radiative lifetime is 7

seconds and 10-11 – 10-9 s in solutions.50,51 The energy diagram is illustrated in Figure 2.
In condensed materials, for example reaction solvents, the high energy excited state
O2(1Σg+)

rapidly converts to the low energy excited state O2(1Δg). 52 Therefore, the

“singlet oxygen” or “singlet O2” is generally referred to the 1Δg state. Only the 1Δg
oxygen is believed to be involved in organic transformations.

Figure 2. Energy diagram for oxygen molecule

Generation of singlet oxygen (1Δg)
Since high excited state singlet oxygen (1Σg+) can be converted to low excited state (1Δg)
rapidly in condensed material, most generation methods can be considered to create the
1

Δg state of singlet oxygen. In the past decades, researchers have developed two major

types of generation methods, photosensitization and chemical generation. Both of these
two methods can be used generate 1O2 in preparative amounts.
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Photosensitized production of singlet oxygen
Photosensitization is a light-activated process, which requires a light-absorbing
photosensitizer, which is often a dye or natural pigment. Photosensitization is the most
convenient method for singlet oxygen generation. As shown in Figure 3, a sensitizer
absorbs the light in a specific wavelength region and is converted to an electronically
excited state (sensitizer*). Then, the energy transfer from the sensitizer* to the oxygen
(3Σg-), produces singlet oxygen and regenerating the sensitizer. The scheme is
oversimplified, as the spin selection rules for the excitation require a triplet state of the
sensitizer* in order to achieve excitation of the triplet ground state of oxgen. Depending
upon the excited state energy of the sensitizer*, both O2(1Σg+) and O2(1Δg) may be formed
by the energy transformation. However, the conversion from O2(1Σg+) to O2(1Δg) occurs
spontaneously with extremely high rate constant in condensed mediums. As a result, only
O2(1Δg) will be generated from photosensitization.

Figure 3. Generation of 1O2 by photosensitization
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A lot of dyes and pigments have been used as photosensitizers, such as Rose Bengal,
methylene blue, porphyrins and phthalocyanines (Figure 4). Different light sources have
also been used in this process, including medium-pressure sodium lamp, tungsten lamp,
xenon and mercury lamps.53 Due to side reaction of peroxide decomposition, ultraviolet
light is not generally used for photosensitization. Since visible light has more than
enough energy to create a sensitizer*,
photosensitizers.

Figure 4. Structure of some photosensitizers

it is the common light source for these
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The singlet oxygen quantum yield is a key property for a photosensitizer. It is defined as
the number of molecules of 1O2 molecules generated for each photon absorbed by a
photosensitizer. The quantum yields of some photosensitizer are listed in Table 1.
Photosensitizer

Solvent

1

2-Acetonaphthone

C6H6

0.71

Benzophenone

C6H6

0.36

Acridine

C6H6

0.83

Rose Bengal

H2O

0.76

Methylene Blue

CH3OH

0.51

Tetraphenylporphine

C6H6

0.66

(BuO)8ZnPc

C6D6

0.47

O2 quantum yield

Table 1. Singlet oxygen quantum yield of some photosensitizer.54

Chemical generation of singlet oxygen
Chemical sources for singlet oxygen generation are quite diverse. Many different
chemical reactions have been developed to produce singlet oxygen. Most of these
reactions need the water-enriched media. The first developed reaction was based upon the
reaction of sodium hypochlorite with H2O2, which produces 1O2 in nearly quantitative
yield.55 Phosphite ozonides, which are produced by reaction of ozone with phosphite, can
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generate 1O2 by decomposition. 56 Many other methods have also been reported, based
upon decomposition of ozone, 57 hydrogen peroxide,

58

hydrotrioxides, 59 and some

inorganic peroxides.60 Generation of 1O2 in organic solvent has been achieved through
thermal decomposition of calcium peroxide,

61

arene endoperoxides,

62

phosphite

ozonides,63 silyl hydrotrioxides, 64 and alkyl hydrotrioxides. 65 Major classes of reaction
for chemical generation of 1O2 are overviewed in Figure 5.

Figure 5. Chemical generation of singlet oxygen

However, the current methods for chemical generation of 1O2 have some drawbacks. The
first one is that most reactions require water-enriched media. 1O2 has a very short lifetime
in aqueous media. The second one is that when applying these reactions for preparative
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purposes, many substrates do not trap 1O2 efficiently, so that a large excess of reagent
must be used to obtain appreciable substrate conversion.

In addition to these chemical sources, a number of other reactions have been found to
produce singlet oxygen in biological systems. 66 Some enzymatic systems have been
suggested to give singlet oxygen. However, most of these sources are still under
investigation.

Chemical reaction of singlet oxygen
Singlet oxygen is a very useful reagent, which could allow the stereoselective and
regioselective introduction of dioxygen into organic molecules. It can react with many
organic compounds, including olefins, dienes, arenes, and sulfide. The reactions with
alkenes are most common, and can be divided into three classes: [4+2] cycloadditions
with 1,3-dienes, [2+2] cycloadditions and ene reactions with isolated double bonds.

[4+2] Cycloaddition with singlet oxygen
In a reaction that appears similar to a Diels-Alder reaction, singlet oxygen can react with
cis-1,3-dienes for form the 6-member endoperoxides. It was once suggested that this
reaction had the same concerted pathway just like the Diels-Alder reaction. However,
recent studies indicates that, the perepoxide intermediate in a stepwise process would
have a lower energy compared with the transition state in concerted pathway. 67 Therefore,
the stepwise pathway has been suggested, and in this pathway, the formation of
perepoxide intermediate would be the rate-determining step (Figure 6).
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Figure 6. Possible reaction pathway for singlet oxygen [4+2] cycloaddition

1,3-butadienes which undergo [4+2] cycloadditions with 1O2 can be classified into 5
different categories: nonhomoannular 1,3-diene, alkenylarenes, homoannular aliphatic
dienes, heterocyclic 1,3-dienes and nonheterocyclic aromatic dienes. These types of
substrates and their reaction products are shown in Figure 7. 68
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Figure 7. Examples of singlet oxygen reaction with dienes

The 1O2 [4+2] cycloaddition reaction to endoperoxide product has many applications.
This reaction has been widely used as key steps in total synthesis of many natural
products, such as Ricciocarpin B (Figure 8).69
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Figure 8. Application of [4+2] cycloaddition in synthesis of Ricciocarpin B

Ene reaction with singlet oxygen
The ene reaction is a type of chemical reaction between an alkene with an allylic
hydrogen (the ene) and a compound containing a π-bond (the enophile), in order to form
a new σ-bond. The version of this that involves a carbon-carbon bond as an enophile is
called an Alder-ene reaction. In the transformation, the double bond of the ene shifts and
new Y-H and C-X σ-bonds are formed (Figure 9).

Figure 9. Ene-reaction

The ene reaction with singlet oxygen was firstly discovered by Schenk in 1943.70 In this
reaction, the alkene with allylic hydrogen substrate is oxidized by singlet oxygen to
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generate an allylic hydroperoxide, where both double bond and allylic hydrogen have
shifted. Study of the mechanism has suggested a stepwise mechanism involving an
intermediate perepoxide (Figure 10). 71

Figure 10. Mechanism of singlet oxygen ene reaction

In the ene reaction, the double bond always shifts to the allylic position, and formation of
the new C-O bond and removal of the hydrogen occurs on the same face of the π system
(suprafacial), and leads to formation of the trans olefin as a major product (Figure 11). 72

Figure 11. Suprafacial selectivity of singlet oxygen ene reaction

The allylic hydroperoxides products of the ene-reaction are important intermediates, and
can undergo a number of different organic transformations (Figure 12). 73
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Figure 12. Examples of transformation from allylic hydroperoxides

[2+2] Cycloaddition with singlet oxygen
Beside the ene reaction, singlet oxygen can also react with olefins to form products
derived from a [2+2] cycloaddition process. The [2+2] cycloaddition with singlet oxygen
is usuallly disfavored compared with the ene reaction.
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However, the [2+2]

cycloaddition will be the dominant if the olefin substrates are extremely electron-rich or
if the substrates lack accessible allylic hydrogens. (Figure 13).
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Figure 13. Competence between [2+2] cycloaddition and ene reaction

Similar with ene reaction, the [2+2] cycloaddition of alkenes with singlet oxygen is a
stepwise process involving a perepoxide intermediate. Rearrangement of the perepoxide
intermediate generates 1,2-dioxetane product (Figure 14).

Figure 14. Mechanism of [2+2] cycloaddition with singlet oxygen

Detection of singlet oxygen
Detection of singlet oxygen can be achieved by luminescence (Figure 15). There are two
types of luminescence from singlet oxygen, the direct “monomol” phosphorescence at
1270 nm,75 and the “dimol” emission at 630 and 701 nm.76
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Figure 15. Luminescence from singlet oxygen

The detection at 1270 nm luminescence has become the standard technique for
investigation of singlet oxygen photochemistry. The lifetime of singlet oxygen in most
solvent systems is ranges from a few microseconds to milliseconds, this luminescence
therefore is very weak, and results a low quantum yield from roughly 10-6 to 10-3. To
observe the luminescence at 1270 nm, specialized detectors has been developed. In the
past decades, the germanium diode detector has been developed as a routine
measurement of this luminescence. 77

The singlet oxygen “dimol” luminescence arises from collision between two molecules of
singlet oxygen and gives rise to a quantum of twice the energy of the monomol, with
emission at 630 and 710 nm. Since this emission requires two molecules, its intensity is
related to singlet oxygen concentration.

Chemical trapping of singlet oxygen
A lot of organic compounds can react with singlet oxygen to give the “fingerprint”
products. Therefore, these chemicals could be used as the chemical trapping reagents in
situ for singlet oxygen in the biological or other systems. Most trapping reagents react
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with singlet oxygen through [4+2] reaction or ene reaction. . Some common trapping
agents are shown in figure 16.

α-terpinene, diphenyl isobenzofuran and 9,10-

diphenylanthracene.

Figure 16. Examples of trapping reagents for singlet oxygen

In addition to these traditional trapping reagents, some new reagents have been developed.
A recent study reported a new anthracene derivative which could be used as a singlet
oxygen trapping reagent via the fluorescent probe (Figure 17).78
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Figure 17. anthracene derivative trapping reagent.

Application of singlet oxygen
Because of its special activity, singlet oxygen has been widely used in many areas. One
major application is the photodynamic therapy, which is used clinically to treat a wide
range of medical conditions.79 In photodynamic therapy, a photosensitizer is used and
absorbs energy from a light source. Then the energy will transfer to the molecular oxygen
in human tissue and create an excited state oxygen molecule, singlet oxygen. Ultimately,
singlet oxygen will react rapidly with nearby biomolecules, which could kill cancer cells.
Another important application of singlet oxygen is to be the source of chemical oxygen
iodine laser.80 The excited singlet oxygen transfers energy to iodine molecule, then the
excited iodine undergoes simulated emission and radiates as laser.

3.2 Result and discussion
In the previous investigation of a “reductive ozonolysis” of alkene, singlet oxygen could
be generated during rearrangement of the intermediate.

81

This transformation was

hypothesized to involve nucleophilic addition of amine N-oxides to short-lived carbonyl
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oxides to generate peroxyanion/oxyammonium acetals. These previously unknown
intermediates were surmised to undergo fragmentation to generate the observed
“reduction” products, along with a molecule of singlet oxygen, and a molecule of amine
(Eq. 1). A similar fragmentation should be possible for any species featuring a geminal
relationship between a peroxyanion and a heterolytically activated O-X bond. Previous
study revealed the reactivity of monoperesters of readily available 1,1-dihydroperoxides.
Deprotonation of these species resulted in rapid fragmentation accompanied by highly
efficient liberation singlet oxygen (Eq. 2). 82

The next section will discuss our investigations of generations of singlet oxygen through
decomposition of derivatives of 1,1-dihydroperoxides.

Range of acetal/ketal scaffolds
I firstly investigated the scaffolds of 1,1-dihydroperoxide substrates. A series of 1,1dihydroperoxides (1a-8a) were prepared through Re(VII)-promoted peroxyacetalization
of the corresponding ketones (Scheme 1).83 Monoacetylation with acetic anhydride and
pyridine furnished isolable monoperesters (1b-4b, 6b, and 7b). The exception was
adamantanone dihydroperoxide (5a), which underwent ring expansion to a lactone upon
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attempted acylation. 1,1-Dihydroperoxides derived from aldehydes reacted to form
highly polar byproducts products, presumably resulting from E1cb fragmentation of
peresters bearing an adjacent C-H.

Scheme 1. Synthesis of 1,1-dihydroperoxides and derived monoperesters

Thermal stability
Dihydroperoxide 1a, which melts without decomposition at 78-80 °C and is not
detonated by a sharp hammer blow, undergoes a highly exothermic decomposition when
heated beyond 100 °C. Monoacetate 1b, is stable for prolonged periods at freezer
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temperature and for days at room temperature, but the onset of an exothermic
decomposition is observed at approximately 76 °C. Monocarbonate 1d undergoes partial
decomposition within days at room temperature to form a substituted caprolactone and
undergoes exothermic decomposition when heated above 70 °C (Figure 18).

1a

1b
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1d
Figure 18. Thermal stability of 1a, 1b, 1d

Assay for 1O2
Based on the synthesized substrates, the assay for 1O2 was tested. The release of 1O2 was
quantified by chemical reaction with terpinene (T) or diphenylisobenzofuran (DPBF, D).
Terpinene undergoes addition of 1O2 to form the stable endoperoxide ascaridole (T-O2 Eq.
3). DPBF undergoes an even more rapid addition to generate diketone D-O2 via an
unstable endoperoxide (Eq. 4). T-O2 and D-O2 are easily quantified through isolation or
by NMR or GC/MS analysis in the presence of an internal standard.
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Variation of the bisperoxyacetal skeleton:
I next investigated the generality of the fragmentation across a range of peroxyacetal
skeletons. Solutions of monoesters 1b-4b, and 6b-8b were decomposed with TBAF in
the presence of 0.5 equiv of terpinene (Table 2); the relative stoichiometry was chosen to
facilitate product separation. Addition of base was accompanied by the disappearance
(TLC) of the monoesters and the appearance of the corresponding ketone and ascaridole
(T-O2). The yield of trapped 1O2 varied little with structural variations in the peroxyacetal.
By comparison, a 1,1-dihydroperoxide (1a) did not react under the reaction conditions.
OOH
+ T (0.5 eq)
OOAc

a

n-Bu4NF (1.2 eq)
CH3CN (r.t.), 0.08h

T-O2

monoperester or diOOH

yield T-O2 a

1b

26%

2b

26%

3b

23%

4b

31%

5b

27%

7b

24%

8b

23%

1a

NR

Yield of T-O2 relative to monoperester

Table 2. Influence of scaffold on reactivity
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Influence of peroxyacetal backbone on relative reactivity
Curious as to the influence of peroxyacetal structure on the relative rate of the reaction, I
investigated the decomposition of mixtures of dihydroperoxide monoesters in the
presence of a limiting amount of TBAF. The results, illustrated in Scheme 3, demonstrate
very little difference in reactivity between acyclic and cyclic substrates (1b and 4b) or
between cyclic substrates possessing different amounts of ring strain (7b and 1b).

Scheme 3. Influence of peroxyacetal backbone

Influence of Solvent
Singlet oxygen has different lifetime in various solvents (Table 3). The lifetimes are
typically 30-100 µs in organic solvents, and could increase to several hundred
microseconds in deuterated organic solvents. In perfluorinated solvent, singlet oxygen
has longest lifetime.
Solvent

Lifetimes (µs)

Slovent

Lifetime (µs)
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H2O

3.8

Acetone

50

D2O

62

d6-Acetone

723

CH3OH

10

CH3CN

62

Hexane

31

CD3CN

554

CH2Cl2

86

C5H5N

16

CHCl3

264

C6H5CH3

27

CDCl3

740

C6D5CD3

320

C6H6

30

Freon-113

15800

C6D6

630

C6F6

3900

Table 3. Lifetime of singlet oxygen in various solvents.84

Decomposition of monoester 1b in a number of solvent systems (Table 4) revealed the
yield of dioxygen transfer (T-O2) to be increased in solvents associated with greater 1O2
lifetime as evidenced by a comparison reaction in CDCl3 vs. CHCl3. The exception was
for perfluorinated media, in which reaction appeared limited by reagent solubility.
However, improved yields were possible in fluorocarbon/CH3CN mixtures.

Solvent

Base

Yield T-O2 a

CH3CN

n-Bu4NF

26%

CHCl3

n-Bu4NF

17%

CDCl3

n-Bu4NF

35%

Acetone-d6

n-Bu4NF

33%
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C6D6

n-Bu4NF

30%

C6F6

n-Bu4NF

7 %b

C6F6

KOtBu

1 %b

C6F6/ CH3CN (9:1)

n-Bu4NF

24 %

C6F6/ CH3CN (1:1)

n-Bu4NF

36 %

C6F14/ CH3CN (1:1)c

n-Bu4NF

28 %

Freon-113/CH3CN (1:1)

n-Bu4NF

39 %

a

Yield of T-O2 based upon 1b; bLimited reagent solubility; cbiphasic

Table 4. Influence of different solvents

Order of addition
In early experiments involving decomposition of monoperester 1b,36 the yield of 1O2 was
observed to sometimes depend upon the order of addition of KOtBu and perester,
suggesting the possibility of disproportionation to form poorly reactive bisperesters (vida
infra). However, I reinvestigated this phenomenon using peracetate 1b and TBAF and
found an insignificant difference (Table 5).

Conditions

Yield T-O2

Add nBu4NF to solution of 1b and T

35%

Add 1b to solution of nBu4NF to and T

38%

Table 5. Influence of order of addition of reagents
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Range of activating groups
Base-promoted decomposition of a perbenzoate (1c) and a percarbonate (1d) proceeded
rapidly to furnish yields of trapped 1O2 similar to those observed for the peracetate (1b)
(Table 6). Attempts to prepare the analogous percarbamate or persulfonate led only to
ring-expansion.

Reagent

Yield of 1c or 1d

Yield T-O2 a

PhCOCl

1c (37%)

24%

EtOC(O)Cl

1d (76%)

20%

PhNCO

decomp

-

TsCl

decomp

-

a

Based upon T-O2 vs. stoichometry of 1c or 1d

Talbe 6. Investigation of other peracyl activating groups

Influence of Base/Counterion
The preliminary work had observed rapid decomposition of the dihydroperoxide
monoesters in the presence of KOtBu, TBAF, or Cs2CO3, but not K2CO3 or KHCO3 and
we decided to further investigate the importance of the counterion. As shown in Table 7,
comparing the decomposition of 1b in the presence of LiN(TMS)2 resulted in much lower
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yields of 1O2 trapping compared to reactions involving the comparably basic KOtBu or
TBAF.

Base

Yield T-O2 a

KOtBu

30%

LiN(SiMe3)2 (in THF)

4.1%

nBu4NF (in THF)

35%

a

relative to stoichometry of perester

Table 7. Investigation of different bases

Effect of temperature and rate of addition:
We then want to look at the effect of temperature and the rate of addition. Not
surprisingly, the TBAF-promoted decomposition of monoperester 1b was observed (TLC)
to proceed significantly faster at higher temperatures; however, the yield of trapped 1O2
was improved at lower temperatures (Table 8, entries 1-4). The base-promoted
decomposition of the 1,1-dihydroperoxide monoesters is rapid; for example, rapid (1-2
sec) injection of 1M THF solution of TBAF into a rapidly stirring solution of monoester
1a (1M in THF) results in immediate effervescence. However, a slow rate of addition
was associated with a significant increase in the yield of trapped 1O2 (entries 5 and 6).
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T

Reaction time

Mixing time

Entry

(°C)

Solvent

(h)

(h)

yield T-O2 c

1

rt

THF

0.25

10-3

10%

2

0

THF

0.25

10-3

13%

3

- 40

THF

0.25

10-3

19%

4

- 78

THF

0.25

10-3

24%

5

rt

CH3CN

0.25

3 x 10-4

24%

6

rt

CH3CN

0.25

0.25

42%

a

nominally 1M in THF. bSingle injection or timed delivery from syringe pump. cYield

T-O2 relative to perester
Table 8. Influence of temperature and rate of addition

Attempted gas-phase transfer
The inverted relationship between the yield of oxygen transfer and the rate of substrate
decomposition (Table 8, entries 5 and 6) led me to investigate whether 1O2 could be
escaping into the gas phase. A septum-covered flask was charged with an acetonitrile
solution of perester 1b and the head space was exhausted via a short Teflon tube into an
acetonitrile solution of terpinene (Figure 19). Rapid (≤ 10 sec) addition of TBAF/THF
into the solution of monoester 1b led to vigorous effervescence and net efflux of a high
volume of gas through the receiving solution.
ascaridole (T-O2) was detected.

However, no significant amount of
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Figure 19. Gas-phase transfer attempt of singlet oxygen generation

Generation of the peroxyanion via nucleophilic desilylation
I investigated an alternative route to the presumed peroxyanion intermediate through
nucleophilic desilylation. Monotrialkylsilylated substrates were readily available via
silylation of the monoesters (Scheme 4). Curiously, the signal corresponding to the
perester carbonyl remained invisible by 13C NMR despite use of pulse delays (≥ 5 sec) or
the addition of Ni(acac)2 as a relaxation agent.85 The peracyl carbon could be observed as
a single sharp signal at 167.8 ppm for spectra acquired at ≤ 40 °C (9a, 9b, 11). However,
this phenomenon was not encountered with either the monoperesters (e.g. 1b) or a
bisperester (16).
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Scheme 4. Synthesis of silylated peresters

Reaction of the silylated monoesters with TBAF in the presence of a trapping agent
resulted in yields of transferred 1O2 equal to or exceeding those observed through
deprotonation of the dihydroperoxide monoesters (Table 9).

Subs

SiR3

t (min)

Trap

Yielda

9a

SiEt3

5

D

33%

9b

TBS

5

D

29%

9b

TBS

5

T

25%

9b

TBS

10

D

25%

10

SiEt3

30

D

34%
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a

11

SiEt3

20

D

37%

12

SiEt3

10

D

41%

13

SiEt3

16

D

38%

14

SiEt3

5

D

28%

Yield of T-O2 or D-O2 relative to peroxide starting material.

Table 9. Frgamentation of silylated dihydroperoxide monoesters

Reactivity of bissilyl and bisacyl derivatives of a 1,1-dihydroperoxide
Preparation of bissilyl and bisacyl derivatives of dihydroperoxide 1a are illustrated in
Scheme 5. The bistriethylsilyl derivative (15) was an oily compound that decomposed at
~ 140 °C. The bisacyl derivative (16) was a solid that melted without decomposition at
54-56 °C. Saponification of 16 with cesium hydroxide in CH3CN resulted in reformation
of the parent ketone and generation of 1O2. 1,1-Dihydroperoxide 1a was unreactive
towards base; the derived bissilyl ether (15) was decomposed by nBu4NF without
apparent transfer of oxygen.
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Scheme 5. Reactivity of bissilyl and bisacyl derivatives of 1,1-dihydroperoxides

Tandem activation and fragmentation
Intrigued by the possibility of generating and decomposing the monoactivated
bisperoxide intermediate in situ, I inverstigated the reactivity of dihydroperoxide 1a with
four classes of reagents anticipated to form an activated derivative: an electron-poor
nitrile, a heteroaromatic known to undergo SNAr reaction with tertiary hydroperoxides, a
sulfonyl chloride, and an acid anhydride. The initial assay qualitatively monitored the
formation of ketone upon addition of base to solutions containing both the 1,1dihydroperoxide 1a and the additive (Table 10).

In each case, the addition of

stoichometric electrophile and excess KOtBu resulted in rapid conversion of the 1,1dihydroperoxide to 4-tert-butylcyclohexanone without any evidence of intermediates.
Although these reactions should in theory require only two equivalents of base, I found
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that four equivalents were invariably required to achieve complete consumption of the
dihydroperoxide.

Activator

KOtBu

t (h)

Convsa

(eq)

a

CCl3CN

2.0

0.75

incomplete

CCl3CN

4.0

≤ 0.1

complete

triazene

2.0

>12

incomplete

triazene

4.0

≤ 0.1

complete

p-TsCl

2.0

0.3

incomplete

p-TsCl

4.0

≤ 0.1

complete

Ac2O

2.0

0.5

incomplete

Ac2O

4.0

0.25

complete

Consumption of 1a (TLC, NMR)

Table 10. Investigation of electrophiles for activation/fragmentation

Then I reinvestigated the most promising conditions in the presence of a trapping agent.
The yields of oxygen transfer were similar regardless of activating agent and proved to be
as good or better as those obtained with the dihydroperoxide monoesters (Table 11).
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a

Activator

t (min)

Yield D-O2 a

CCl3CN

5

36%

triazene

5

39.5%

p-TsCl

5

39%

Ac2O

5

31%

relative to dihydroperoxide 1a

Table 11. Oxygen transfer via in-situ activation

Preparative Reactions
I investigated the amount of reagent necessary to completely consume a trapping reagent
using either the fragmentation of a preformed perester (1b, 8b) or the tandem
activation/fragmentation of dihydroperoxide 1a. As illustrated in Table 12, complete
consumption of terpinene could generally be achieved with as little as 5 equiv of reagent.
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a

Subs (eq)

Trap

Reagents (eq)

t (min)

Product ( yielda )

1b (5)

T

TBAF (5)

10

T-O2 (83%)

1b (6)

T

TBAF (6)

10

T-O2 (100%)

1b (2.5)

D

TBAF (2.5)

5

D-O2 (100%)

1a (5)

T

triazine (5), KOtBu (20)

15

T-O2 (69%)

1a (7)

T

triazine (7), KOtBu (28)

15

T-O2 (100%)

8b (6)

T

TBAF (6)

10

T-O2 (100%)

yield of T-O2 or D-O2

Table 12. Investigation of preparative conditions

Reaction order and apparent rate constant
To gain information about the reaction rate and order, I followed the base-promoted
decomposition of monoperbenzoate 1c at 272 nm (Figure 20). In the first experiment,
rapidly stirred THF solutions (0.5 mM) of dihydroperoxide monoester 1c in a cuvette
were mixed with a series of THF solutions of TBAF ranging in concentration from 0.5 to
2.00 mM. The reaction solutions were then placed in the UV spectrophotometer, and the
absorbance at 272 nm monitored for 1.0 minute.

Plotting the log of the initial

concentration of TBAF against the negative log of the change in absorbance revealed an
apparent reaction order of 0.94 in TBAF and a calculated rate constant of 102 L/mol-sec.
Repeating the experiment with a constant concentration of TBAF and varying
concentrations of 1c indicated an order of 1.2 in peroxide and a calculated rate constant
of 102 L/mol-sec. Overall, the results support a mechanism that is first-order in both
peroxide and base.
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Figure 20. Monitoring rate of decompositions

Theoritical investigations
Collaborators Dr. Kuwata and his group in Macalester College finished the theoretical
study of this new fragmentation.
The base-promoted fragmentation of the monoactivated 1,1-dihydroperoxides could
conceivably involve a concerted Grob-like fragmentation. B3LYP/6-31+G(d,p)
calculations suggest a concerted fragmentation to offer the lowest energy pathway for
generation of 1O2 and a carbonyl. The alternative pathway is disfavored both by the strain
in the trioxetane intermediate, presumably reflecting electron pair repulsions, as well as
by the high barrier for loss of 1O2 (Figure 21). The detailed results were reported in J. Org.
Chem, 2012, 77, 1233.
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Discussions
This reaction constitutes a new class of fragmentation involving a peroxyanion geminally
linked to an electrophilically activated peroxide (Figure 22). The peroxyanion
intermediate can be generated by deprotection, nucleophilic desilylation, or deacylation,
but it must be highly dissociated. The data from competition reactions suggests that
deprotonation may be rate limiting.
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Figure 22. Mechanistic overview

The ability to achieve tandem activation and fragmentation of readily available 1,1dihydroperoxides is noteworthy. Hydroperoxyimidates, while not isolable, have been
postulated as short-lived intemediates in epoxidations. 86 Peroxytriazenes, which have
been prepared from SNAr reactions of tertiary hydroperoxides, have mainly been of
interest as radical sources.87

The observation of more efficient oxygen transfer in deuterated or halogenated solvents is
not surprising given the enhanced lifetime 1O2 in solvent lacking C-H, O-H, or N-H
bonds. The failure of the results to scale linearly to 1O2 lifetime results from the fact that
the trapping substrate is by definition a potent quenching agent. However, the observation
of an inverted relationship between the rate of fragmentation and the yield of trapped 1O2
remains perplexing. The lifetime of 1O2 in organic solvent varies little with temperature.88
The reaction of 1O2 with electron-rich alkenes has a near-zero enthalpy of activation and
a strongly negative entropy of activation;89 photosensitized oxygenations are often quite
rapid even at low temperature. The observations of lower trapping yields at higher
reaction rates suggest quenching or loss of 1O2. However, there is no evidence of either
1

O2 escape into the gas phase nor any luminescence or other evidence of dimol

quenching.90

3.3 Experimental Section
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Standard procedure for preparation of 1,1-dihydroperoxide (illustrated for 1a)
To a stirred room temperature solution of 4-tert-Butylcyclohexanone (0.50 mmol) and
Re2O7 (0.025 mmol, 5 mol%) in CH3CN (typically 3 mL, but up to 8 mL in the case of 1h)
was added 50% aqueous H2O2 (112 µL, 2.0 mmol). Following consumption of ketone
(TLC), the reaction mixture was passed through a plug of silica, which was washed with
EtOAc. Following partial concentration in vacuo, the residue was purified by flash
column chromatography to give a white solid 1a.
HOO

OOH

1,1-Dihydroperoxy-4-tert-butylcyclohexane (1a): 84%, white solid, mp 8183°C, Rf = 0.33 (30% EA/Hex), other physical data were identical to literature reports.41

HOO

OOH

1,1-Dihydroperoxycycloheptane (2a): 83%, white solid, mp 59-61°C, Rf = 0.33
(30% EA/Hex), other physical data were identical to literature reports. 41

HO O

OO H

1,1-Dihydroperoxycyclooctane (3a): 58%, colorless oil, Rf = 0.33 (30%
EA/Hex), other physical data were identical to literature reports. 41
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HOO

OOH

4-Phenyl-2,2-dihydroperoxybutane (4a): 72%, white solid, mp 6163°C, Rf = 0.36 (40% EA/Hex), other physical data were identical to literature reports.41

OOH

OOH

1,1-Dihydroperoxyadamantane (5a): 88%, white solid, mp 148-150°C, Rf =
0.30 (30% EA/Hex), other physical data were identical to literature reports.41

H OO

OOH

5,5-Dihydroperoxynonane (6a): 75%, colorless oil. Rf = 0.25
(20% EA/Hex), other physical data were identical to literature reports.41
HOO

O OH

1,1-Dihydroperoxy-3-tert-butylcyclopentane (7a): 84%, colorless oil. Rf =
 9.83 (s,

0.30 (30% EA/Hex), IR: 3420, 2956, 2870, 1365, 1104, 963 cm-1; 1H
2H), 2.05 (m, 2H), 1.9 (m, 2H), 1.7 (m, 2H), 1.47 (m, 1H), 0.85 (s, 9H);

13

C NMR 

121.7, 49.2, 34.5, 32.6, 31.5, 27.4, 25.6; HRMS (ESI, MeOH/H2O, NaOAc), calc. for
C9H18NaO4 (M+Na)+: 213.1103; found 213.1110
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OO H
OO H

1,1-Dihydroperoxycyclododecane (8a): 93%, colorless oil, Rf = 0.33 (30%
EA/Hex), other physical data were identical to literature reports.41

Standard

procedure

for

preparation

of

1,1-dihydroperoxide

monoacetate

(illustrated for 1b):
To a solution of 4-tert-butylcyclohexyl-1,1-dihydroperoxide 1a (1.48 g, 7.2 mmol) in
CH2Cl2 (15 mL), was added DMAP (0.09 g, 0.75 mmol), and pyridine (0.57 g, 7.2 mmol).
The reaction mixture was cooled to 0 oC and a solution of Ac2O (0.74 g, 7.2 mmol) in
CH2Cl2 (10 mL) was added dropwisely over 10 min. Upon completion of addition, the
reaction was stirred for 30 min at 0 °C, and then diluted with CH2Cl2 (100 mL). The
solution was washed with saturated NaHCO3 (20 mL), water (20 mL), brine (20 mL), and
then dried over anhydrous Na2SO4. The residue obtained upon removal of the solvent in
vacuo was purified by silica flash chromatography (5% EA/Hex) to give a white solid
(1.47 g, 84% yield).
The acid anhydride could be replaced by acid chloride (peresters) or ethoxycarbonyl
chloride (percarbonates) without any other change.
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HOO

OOAc

1-Acetyldioxy-1-hydroperoxy-4-tert-butylcyclohexane (1b): 84%, white solid,
mp 35-37°C. Rf = 0.33 (10% EA/Hex); other physical data were identical to literature
reports.40

HOO

OOAc

1-Acetyldioxy-1-hydroperoxycycloheptane (2b): 76%, colorless oil. Rf = 0.33
(10% EA/Hex); IR: 3345, 2930, 2859, 1756, 1425, 1171, 1006, 899 cm-1;
10.13 (s, 1H), 2.09 (2, 3H), 1.92 (m, 4H), 1.54 (br, 8H);

13



1

C NMR  171.7, 117.4, 32.5,

29.6, 22.6, 17.5; HRMS (ESI, MeOH/H2O, NaOAc), calc. for C9H16NaO5 (M+Na)+:
227.0895; found 227.0898

HO O

OOAc

1-Acetyldioxy-1-hydroperoxycyclooctane (3b): 73%, colorless oil. Rf = 0.33
 10.13 (s,

(10% EA/Hex); IR: 3340, 2924, 1756, 1409, 1200, 1078, 898 cm-1 ; 1
1H), 2.15 (s, 3H), 2.00 (m, 2H), 1.89 (m, 2H), 1.63 (br, 4H), 1.57 (br, 6H);

C NMR 

13

171.7, 116.8, 27.8, 27.4, 24.9, 21.8, 17.6; HRMS (ESI, MeOH/H2O, NaOAc), calc. for
C10H18NaO5 (M+Na)+: 241.1052; found 241.1046
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HOO

OOAc

4-Phenyl-1-acetyldioxy-1-hydroperoxybutane (4b): 86%, colorless
oil. Rf = 0.33 (10% EA/Hex); IR: 3340, 2988, 2900, 1758, 1378, 1066, 899, 748, 698 cm1; 1H NMR  10.39 (s,1H), 7.35 (m, 2H), 7.28 (m, 3H), 2.86 (m, 2H), 2.24 (dd, J = 5.46,
12.9 Hz, 1H), 2.20 (s, 3H), 2.09 (dd, J = 5.46, 12,2 Hz, 1H), 1.61 (s, 3H);

13

C NMR 

171.7, 141.0, 128.6, 128.4, 126.3, 113.7, 34.9, 30.2, 18.1, 17.6; HRMS (ESI, MeOH/H2O,
NaOAc), calc. for C12H16NaO5 (M+Na)+: 263.0895; found 263.0899

H OO

OOA c

5-Acetyldioxy-5-hydroperoxynonane (6b): 76%, colorless oil.
Rf = 0.33 (10% EA/Hex); IR: 3350, 2960, 2873, 1760, 1198, 1056, 899 cm-1; 1H NMR 
10.13 (s, 1H), 2.12 (s, 3H), 1.73 (m, 2H), 1.56 (m, 2H), 1.34 (m, 8H), 0.90 (t, J = 7.15 Hz,
3H);

C NMR  171.6, 116.0, 28.9, 25.6, 22.7, 17.4, 13.8; HRMS (ESI, MeOH/H2O,

13

NaOAc), calc. for C11H22NaO5 (M+Na)+: 257.1365; found 257.1361

HOO

OOAc

1-Acetyldioxy-1-hydroperoxy-3-tert-butylcyclopentane (7b): 84%, colorless
oil. Rf = 0.33 (10% EA/Hex); IR: 2959, 2869, 1758, 1365, 1184, 1070, 962; 1H NMR 
10.516/10.501 (two s, totaling 1H), 2.17 (s, 3H), 2.0 (m, 4H), 1.75 (m, 2H), 1.54 (m, 1H),
0.88 (s, 9H);

13

C NMR  171.6, 122.9, 122.8, 49.3, 49.2, 34.6, 34.5, 32.7, 32.6, 31.6,

27.38, 27.36, 25.6, 17.6; HRMS (ESI, MeOH/H2O, NaOAc), calc. for C11H20NaO5
(M+Na)+: 255.1208; found 255.1199

86

OOAc
HOO

1-Acetyldioxy-1-hydroperoxycyclododecane (8b): 81% colorless oil. Rf =
0.33 (10% EA/Hex);. IR: 3307, 2946, 2851, 1748, 1426, 1190, 997, 850 cm-1; 1H
 10.22 (s, 1H), 2.17 (s, 3H), 1.76 (m, 2H), 1.59(m, 6H), 1.39 (br, 14H);

13

C

NMR  171.7, 116.8, 26.1, 25.9, 25.8, 22.1, 21.8, 19.3, 17.7; HRMS (ESI, MeOH/H2O,
NaOAc), calc. for C14H26NaO5 (M+Na)+: 297.1678; found 297.1679

O

HO O

O

O

Ph

1-Benzoyldioxy-1-hydroperoxy-4-tert-butylcyclohexane (1c), 37%,
white solid, mp 76-78 °C, Rf = 0.43 (10% EA/hex), other physical data were identical to
literature reports.40

87
O

HO O

O

O

OEt

4-tert-Butyl-1-hydroperoxycyclohexyl ethyl carbonoperoxoate (1d),
76%, colorless oil, Rf = 0.22 (10% EA/Hex), other physical data were identical to
literature reports.40

Standard procedure for preparation of monosilylated peresters (illustrated for 8a)
To a solution of monoacetate 1b (2.46 g, 10 mmol) in CH2Cl2 (150 mL), was added
DMAP (0.24 g, 2.0 mmol), and Et3N (2.7 ml, 20 mmol), The reaction mixture was cooled
to 0 oC and a solution of TESCl (1.5 g, 10 mmol) in CH2Cl2 (50 mL) was added dropwise
over 10 min. The
reaction was stirred for 30 min at 0 °C, and then the solvent was removed in vacuo. The
residue obtained was purified by silica flash chromatography (5% EA/Hex) to give a
colorless oily product (2.09 g, 58% yield).

TESO O

OOAc

1-Acetyldioxy-1-triethylsilyldioxy-4-tert-butylcyclohexane

(9a):

58%,

colorless oil, Rf = 0.65 (20% EA/Hex); IR 2954, 1777, 1366, 1180, 865 cm-1; 1H NMR 
2.33 (d, J = 14.48Hz, 2H), 2.15 (s, 3H), 1.70 (d, J = 13.2Hz, 2H), 1.46 (dt, J = 3.78,
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13.8Hz, 2H), 1.30 (m, 2H), 1.05 (m, 1H), 0.98 (t, J = 7.69Hz, 9H), 0.87 (s, 9H), 0.69 (dd,
J = 7.55, 16.27Hz, 6H) ;

13

C NMR (233K)  167.9, 110.6, 47.2, 32.5, 30.4, 27.7, 23.2,

18.3, 7.0, 3.4; HRMS (ESI, MeOH/H2O, NaOAc), calc. for C18H36NaO5Si (M+Na)+:
383.2230; found 383.2224

TBSOO

OOAc

1-Acetyldioxy-1-tert-butyldimethylsilyldioxy-4-tert-butylcyclohexane (9b):
TESCl was replaced by TBSCl without any other change, 65%, colorless oil. R f = 0.65
(20% EA/Hex); IR: 2954, 2859, 1777, 1365, 1178, 873, 830, 784 cm-1 ; 1H NMR  2.33
(m, 2H), 2.14 (s, 3H), 1.68 (m, 2H), 1.46 (dt, J = 3.85, 13.63Hz, 2H), 1.29 (m, 2H), 1.05
(m, 1H), 0.93 (s, 9H), 0.87 (s, 9H), 0.14 (s, 6H); 13C NMR (233K)  167.9, 110.7, 47.2,
32.5, 30.4, 27.7, 26.3, 23.2, 18.6, 18.3 ; HRMS (ESI, MeOH/H2O, NaOAc), calc. for
C18H36NaO5Si (M+Na)+: 383.2230; found 383.2235

TESOO

OOAc

1-Acetyldioxy-1-triethylsilyldioxycycloheptane (10): 81%, colorless oil. Rf
= 0.65 (20% EA/Hex); IR: 2969, 1776, 1409, 1170, 1056, 796 cm-1 ; 1H NMR  2.08 (s,
3H), 1.95 (m, 4H), 1.55 (br, 8H), 0.97 (t, J = 7.86 Hz, 9H), 0.68 (q, 6H);

C NMR 

13
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115.9, 33.0, 30.2, 22.8, 17.8, 6.6, 3.7; HRMS (ESI, MeOH/H2O, NaOAc), calc. for
C15H30NaO5Si (M+Na)+: 341.1760; found 341.1759

TES OO

OOA c

1-Acetyldioxy-1-triethylsilyldioxycyclooctane (11): 70%, colorless oil. Rf =
0.65 (20% EA/Hex); IR: 2956, 1776, 1363, 1184, 1066, 833, 729 cm-1; 1H NMR  2.10 (s,
3H), 1.97 (m, 4H), 1.56 (br, 10H), 0.97 (t, J = 7.63 Hz, 9H), 0.68 (q, 6H);

13

C NMR

(233K)  168.1, 115.0, 27.8, 27.2, 24.7, 22.0, 18.2, 7.0, 3.7; HRMS (ESI, MeOH/H2O,
NaOAc), calc. for C16H32NaO5Si (M+Na)+: 355.1917; found 355.1906

TESOO

OOAc

4-Phenyl-1-acetyldioxy-1-triethylsilyldioxybutane

(12):

79%,

colorless oil. Rf = 0.65 (20% EA/Hex); IR: 2957, 1780, 1182, 1103, 825, 698 cm-1 ; 1H
NMR  7.31 (m, 2H), 7.23 (m, 2H), 2.78 (t, J = 8.95 Hz, 2H), 2.15 (m, 5H), 1.57 (s, 3H),
1.04 (t, J = 7.95 Hz, 9H), 0.75 (q, 6H);

13

C NMR  141.3, 128.5, 128.3, 126.1, 111.9,

35.5, 30.4, 18.5, 17.8, 6.7, 3.7; HRMS (ESI, MeOH/H2O, NaOAc), calc. for
C18H30NaO5Si (M+Na)+: 377.1760; found 377.1756
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TES OO

OOA c

1-Acetyldioxy-1-triethylsilyldioxynonane (13): 73%, colorless
oil. Rf = 0.65 (20% EA/Hex); IR: 2959, 1781, 1409, 1184, 1066, 802, 729 cm-1 ; 1H NMR
 2.04 (s, 2H), 1.69 (m, 2H), 1.30 (br, 8H), 0.93 (t, J = 7.85 Hz, 9H), 0.85 (t, J = 6.35Hz,
6H), 0.63 (q, 6H); 13C NMR  114.1, 29.6, 25.5, 22.7, 17.7, 13.7, 6.5, 3.6; HRMS (ESI,
MeOH/H2O, NaOAc), calc. for C18H30NaO5Si (M+Na)+: 377.1760; found 377.1768

OOAc
TESOO

1-Acetyldioxy-1-triethylsilyldioxycyclododecane (14): 80%, colorless oil.
Rf = 0.65 (20% EA/Hex); IR: 2929, 1779, 1470, 1186, 1003, 851, 728 cm-1; 1H NMR 
2.08 (s, 3H), 1.73 (m, 4H), 1.37 (br, 18H), 0.96(t, J = 7.96 Hz, 9H), 0.66 (q, 6H);

13

C

NMR  114.9, 26.7, 26.1, 26.0, 22.3, 21.9, 19.4, 6.7, 3.7; HRMS (ESI, MeOH/H2O,
NaOAc), calc. for C20H40NaO5Si (M+Na)+: 411.2543; found 411.2536

TESOO

OOTES

1,1-Triethylsilyldioxy-4-tert-butylcyclohexane (15)
To a solution of 4-tert-butylcyclohexyl-1,1-dihydroperoxide 1a (0.50 g, 2.5 mmol) in
DMF (30 mL), was added Et3N (0.76 ml, 5.4 mmol), The reaction mixture was cooled to
-40 oC and TESCl (0.91 ml , 5.4 mmol) was added. The reaction was stirred for 1 hour at
-40 °C. Upon completion of addition, the reaction was added with brine (100 mL). The
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solution was washed extracted with hexane (50 ml) three times and then combined
organic layer was dried over anhydrous Na2SO4. The residue obtained upon removal of
the solvent in vacuo was purified by silica flash chromatography (5% EA/Hex) to give
colorless oil. (0.57g, 53%), Rf = 0.80 (20% EA/Hex), other physical data were identical
to literature reports.91

AcOO

OOAc

1,1-Diacetyldioxy-4-tert-butylcyclohexane (16)
To a solution of 4-tert-butylcyclohexyl-1,1-dihydroperoxide 1a (1.48 g, 7.2 mmol) in
CH2Cl2 (15 mL), was added DMAP (0.09 g, 0.75 mmol), and pyridine (0.57 g, 7.2 mmol).
The reaction mixture was cooled to 0 oC and a solution of Ac2O (1.48 g, 14.4 mmol) in
CH2Cl2 (10 mL) was added dropwise over 10 min. Upon completion of addition, the
reaction was stirred for 30 min at 0 °C, and then diluted with CH2Cl2 (100 mL). The
solution was washed with saturated NaHCO3 (20 mL), water (20 mL), brine (20 mL), and
then dried over anhydrous Na2SO4. The residue obtained upon removal of the solvent in
vacuo was purified by silica flash chromatography (10% EA/Hex) to give a white solid
(1.55 g, 75% yield). mp 54-56 °C; Rf = 0.30 (20% EA/Hex); IR: 2960, 2869, 1785, 1361,
1187, 1057, 896 cm-1; 1H NMR  2.34 (d, J = 12.81 Hz, 2H), 2.08 (s, 3H), 2.07 (s, 3H),
1.75 (d, J = 14.12 Hz, 2H), 1.62 (m, 2H), 1.31 (m, 2H), 1.09 (m, 1H), 0.86 (s, 9H);

13

C

NMR  167.5, 167.4, 111.5, 47.1, 32.2, 30.1, 27.5, 23.2, 17.5, 17.4; HRMS (ESI,
MeOH/H2O, NaOAc), calc. for C14H24NaO6 (M+Na)+: 311.1471; found 311.1467
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Standard procedure for fluoride-mediated decomposition of silylated monoesters:
To a solution of 9a (77 mg, 0.2 mmol) and 1,3-diphenylisobenzofuran (DPBF, D, 27 mg,
0.1 mmol) in CH3CN (2 ml), was injected TBAF (1M in THF, 0.24 ml, 0.24 mmol)
within 5 seconds, and the reaction mixture stirred at room temperature for 5 minutes.
Then solvent was removed by vacuum, and the residue was purified by column
chromatography on silica gel to give the pure product D-O2 (19 mg, 66%)

NMR method for quantification of oxygen transfer (illustrated for dioxygenation of
terpenine)
To a solution of 1b (50 mg, 0.2 mmol) and α-terpinene (T, 90%, 15 mg, 0.1 mmol) in
CH3CN (2 ml), TBAF (1M in THF, 0.24 ml, 0.24 mmol) was injected within 5 seconds,
and the reaction mixture stirred at room temperature for 5 minutes. Then solvent was
removed by vacuum. Internal standard 1,2- dichloroethane was added and T-O2 was
measured by NMR.
The alkene peak at 6.3 ppm (dd, J = 8.56, 25.93Hz) of T-O2 will be used for calculation
via following equations:
Actual MoleT-O2 = Molestandard*2*AreaT-O2/Areastandard
Therefore, the calculated %yield = 100*Actual MoleT-O2/Theoretical MoleT-O2
Alternatively, quantification of T-O2 can be conducted by GC/MS using a reported
procedure 5

GC/MS quantification of relative reactivity of dihydroperoxide monoesters
(Illustrated for 1b and 4b)
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Prepare a standard solution of 4-tert-butylcyclohexanone (1 mmol) and benzylacetone (1
mmol) in CH3CN (2 ml) . The standard ratio α = Area4-tert-butylcyclohexanone
standard/Areabenzylacetone standard.

The mole ratio of the ketone products from the competitive

reaction is Area4-tert-butylcyclohexanone actual/( α*Areabenzylacetone actual)

Standard

procedure

for

tandem

activation

and

decomposition

of

1,1-

dihydroperoxides (Illustrated for CCl3CN activator)
To a solution of 1a (41 mg, 0.2 mmol), CCl3CN (29 mg, 0.2 mmol) and 1,3diphenylisobenzofuran (DPBF, D, 27 mg, 0.1 mmol) in CH3CN (2 ml), was added
KOtBu (90 mg, 0.8 mmol). The reaction was monitored by TLC and stirred at room
temperature for 5 minutes. Then solvent was removed by vacuum, and the residue was
purified by column chromatography on silica gel to give the pure product D-O2 (21 mg,
72% yield based upon D or 36% based upon consumed 1,1-dihydroperoxide).

Investigations of Reaction Order and Reaction Kinetics
Part I. Fixed monoperester concentration unchanged, variable [TBAF].
O

HOO

OO

O

Ph

TBAF

+

1

O2

MeCN

tBu

tBu

Conditions: 0.5mM monoperester 3mL, TBAF 15μL: Rapidly stirred THF solutions (0.5
mM) of dihydroperoxide monoester 1c in a cuvette were individually treated with a series
of THF solutions of TBAF ranging in concentration from 0.5 to 2.00 mM. The reaction
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solutions were mixed and the cuvettes then placed in the UV spectrophotometer, with the
absorbence at 272 nm monitored for 1.0 minute.

V0 = k × [Monoperester]0m × [TBAF]0n
d [Monoperester]0
= k × [Monoperester]0m × [TBAF]0n
dt
Abs = e × b × [Monoperester]
-

d (Abs)0
= k × [Monoperester]0m × e × b × [TBAF]0n
dt
K1 = k × [Monoperester]0m × e × b

-

d (Abs)0
= K1 × [TBAF]0n
dt
æ d (Abs)0 ö
Lg ç ÷ = n × Lg ([TBAF]0 )+ Lg (K1 )
dt ø
è
-

At the initial point, V0 is the initial rate, (Abs)0 is the initial absorbance, [Monoperester]0
and [TBAF]0 are the initial concentration

[TBAF]0/mM

-d(Abs)0/dt

Lg([TBAF]0)

Lg(-d(Abs)0/dt)

0.50

0.0302

-0.301

-1.520

0.75

0.0339

-0.125

-1.470

1.00

0.0524

0.000

-1.281

1.25

0.0647

0.097

-1.189

1.50

0.0789

0.176

-1.103

1.75

0.0845

0.243

-1.073

2.00

0.1055

0.301

-0.977

Then plot Lg(-d(Abs)0/dt) vs Lg([TBAF]0)
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Lg([TBAF]0)
-0.200

0.200

0.400
Lg(-d(Abs)0/dt)

-0.400

-0.600
0.000
-0.800
-1.000
-1.200
-1.400

y = 0.9403x - 1.2829

-1.600
-1.800

n = 0.9403. This indicates the reaction is a first order reaction to TBAF reactant
K1 = 0.05213 L × mmol-1 × s-1

Part II. Fixed TBAF concentration unchanged, variable [Monoperester]
O

HOO

OO

O

Ph

TBAF

+

1

O2

MeCN

tBu

tBu

Conditions: Monoperester 3mL, TBAF 0.3M 15μL: The experiment described above was
repeated except that the concentration of TBAF was held constant while the
concentration of 1c was varied.
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V0 = k × [Monoperester]0m × [TBAF]0n
d [Monoperester]0
= k × [Monoperester]0m × [TBAF]0n
dt
Abs = e × b × [Monoperester]
-

d (Abs)0
= k × [Monoperester]0m × e × b × [TBAF]0n
dt
K 2 = k × [TBAF]0n × e × b

-

d (Abs)0
= K 2 × [Monoperester]0m
dt
æ d (Abs)0 ö
Lg ç = m × Lg ([Monoperester]0 )+ Lg (K 2 )
dt ÷ø
è
-

At the initial point, V0 is the initial rate, (Abs)0 is the initial absorbance, [Monoperester]0
and [TBAF]0 are the initial concentration

[Monoperester]0/mM

-d(Abs)0/dt

Lg([Monoperester]0)

Lg(-d(Abs)0/dt)

0.3

0.0352

-0.523

-1.453

0.4

0.0551

-0.398

-1.259

0.5

0.0695

-0.301

-1.158

0.6

0.0824

-0.222

-1.084

0.7

0.111

-0.155

-0.955

0.8

0.113

-0.097

-0.947

0.9

0.133

-0.046

-0.876
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Lg([Monoperester]0)
0
-0.6

-0.5

-0.4

-0.3

-0.2

-0.1

0
-0.2

-0.6
-0.8
y = 1.1862x - 0.8094
-1
-1.2
-1.4
-1.6

m = 1.1862. This indicates the reaction is a first order reaction to Peroxide reactant
K2 = 0.1551 L × mmol-1 × s-1

Part III. Calculation of apparent rate constant.

Abs = e × b × [Monoperester]
[Monoperester]/mM

Abs

0.3

0.323

0.4

0.405

0.5

0.511

0.6

0.612

0.7

0.732

0.8

0.827

0.9

0.927

Lg(-d(Abs)0/dt)

-0.4
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1.0

1.036

1.200
y = 1.0332x

1.000

Abs

0.800
0.600
0.400
0.200
0.000
0.0

0.2

0.4

0.6
[Peroxide]/mM

e × b =1.0332 L × mmol-1

With Part I result:
K1 = 0.05213 L × mmol-1 × s-1, [Monoperester]0 = 0.5 mmol × L-1

K1 = k ×[Monoperester]0 × e × b
k = 0.101 L × mmol-1 × s-1
With Part II result
K2 = 0.1551 L × mmol-1 × s-1, [TBAF]0 = 1.5 mmol × L-1

K2 = k ×[TBAF]0 × e × b
k = 0.100 L × mmol-1 × s-1
Therefore the reaction constant k is 0.101 L × mmol-1 × s-1

0.8

1.0

1.2
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Chapter 4
Synthesis of a tetramic acid as a standard for identification of an intermediate in
HSAF biosynthesis
(Portions of the material in this chapter have been published: Lili Lou, Guoliang Qian,
Yunxuan Xie, Jiliang Hang, Haotong Chen, Kathia Zaleta-Rivera, Yaoyao Li, Yuemao
Shen, Patrick H. Dussault, Fengquan Liu, Liangcheng Du, Biosynthesis of HSAF, a
Tetramic Acid-Containing Macrolactam from Lysobacter enzymogenes, J. Am. Chem.
Soc., 2011, 133, 643-645)

4.1 Introduction
Heat stable antifungal factor (HSAF) is a kind of polyketide compound produced by the
bacterium Lysobacter enzymogenes strain C3, which is used as a biological control agent
for fungal disease of plants.92 The strain C3 has been demonstrated to be able to control
many fungal diseases, including Bipolaris sorokiniana, 93 Fusarium graminearum, 94
Rhizoctonia solani,95 and Uromyces appendiculatus.3 This novel polyketide compound
HSAF, which usually affects formin-mediated microfilament assembly at hyphal tips, can
also disrupt the formation of stable polarity axes, and thus exhibits a very high potential
antifungal activity.96
Structurally, HSAF is a type of macrolactam, containing a tetramic acid (2,4pyrrolidinedione) skeleton within a macrocycle fused onto a 5,5,6-tricyclic ring system.
The tetramic acid skeleton is found widely in natural products, including Alteramide A,97
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and Aburatubolactam A,98 and has been reported to be a key structural feature in terms of
biological activity. (Figure 1).99

Figure 1. Structures of tetramic acid, HSAF and related tetramic acid-containing
macrolactams.

Dr. Liangcheng Du and coworkers (UNL Department of Chemistry) reported four HSAF
biosynthetic genes, including a hybrid polyketide synthase/nonribosomal peptide
synthetase (PKS/NRPS). Once they had the complete sequence of the gene cluster based
on the genome sequences, they expressed the NRPS module and demonstrated in vitro
that it can specifically convert two acyl thioesters and L-ornithine thioester to a tetramate
product (Figure 2).

However, in order to confirm the structure of the biosynthetic

product, the Du group required an authentic sample for comparison. Our collaboration
focused on the synthesis of this tetramic acid.
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Figure 2. Proposed mechanism for biosynthesis of tetramic acid-containing product

4.2 Results and discussion
The tetramic acid skeleton is generally synthesized using a Dieckmann intramolecular
condensation as the key step.100 The Dieckmann condensation involves the attack of an
ester enolate or similar nucleophile on an ester or related acyl group to generate βketoesters.101 Several results had been reported to prepare tetramic acid derivatives via
Dieckmann condensation (Figure 3).102, 103

Figure 3. Tetramic acid preparation via Dieckmann condensation.

An alternative method for the preparation of the tetramic acid skeleton involves treatment
of a N-protected amino acid with Meldrum’s acid in the presence of N,Ndimethylaminopyridine and isopropenyl chloroformate to afford an intermediate, which
rearranges to a tetramic acid upon heating (Figure 4). .104
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Figure 4. Alternative synthesis of tetramic acid

Recently, another method for synthesis of tetramic acid derivatives has been reported
(Figure 5). 105 The reaction of carbonyldiimidazole and α-diimines led to the N-alkyl-4alkylamino-5-methylenepyrrol-2-ones intermediates, which could be converted to
tetramic acid derivatives in two steps.

Figure 5. Synthesis of tetramic acid derivatives.

A retrosynthetic summary of our planned approaches to the target molecule is illustrated
in Figure 6. Three synthetic routes were investigated in our efforts to prepare the target
tetramic acid. All employ Dieckmann condensation as the key step to construct the
tetramic acid ring skeleton.
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Figure 6. Retrosynthetic analysis

The first route, illustrated in Scheme 1, begins with bisacylation of L-ornithine methyl
ester (2) with stearoyl chloride to furnish diamide (3). However, the planned Dieckmann
condensation failed to furnish the desired target tetramic acid under a variety of standard
conditions, including the use of KOtBu, LDA, LiHMDS, or nBuLi as bases.106

Scheme 1. Attempt of target synthesis
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Scheme 2 illustrates an alternative route to the tetramic acid based upon Dieckmann
condensation using the stabilized enolate derived from a 1,3-dicarbonyl as a nucleophile.
The approach began with the N5 monocarbamate of L-ornithine methyl ester, which was
acylated at N2 with the acid chloride of a malonic acid monoester. This intermediate
underwent successful Dieckmann condensation with in the presence of soidum methoxide
to furnish intermediate 6, a carboxyethyl derivative of a tetramic acid. Then
decarboxylation of 6 in CH3NO2/H2O led to intermediate 7. Unfortunately, attempted
introduction of the hexadecyl side chain introduction to C3 position of the 3,5dioxopyrrolidine failed in the typical condition of NaH/THF. This reaction instead
furnished the enol ether derived from O-alkylation as the only product. A similar result
has been previously reported during attempted alkylation of tetramic acid ring systems
with a long-chain electrophile,
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suggesting that we needed to identify a route that

would introduce the hexadecyl sidechain prior to tetramic acid formation.
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Scheme 2. Attempt of target synthesis

The successful approach to the target (Scheme 3) took advantage of the lessons gained in
the previous route by incorporating the hexadecyl sidechain in the malonic ester deriative
used to acylate the N2 of ornithine. The synthesis began with the boroxazolidinone
adduct of L-ornithine, which was selectively acylated at the terminal amino group with
octadecanoyl chloride to furnish a monoamide.108 Deprotection of the boroxazolidinone
with ethylenediamine, followed by reaction with thionyl chloride in methanol, furnished
methyl ester 11. Conversion of the amino acid ester to the tetramic acid was
accomplished through a modification of a published approach. 109 Condensation of the
amino ester with 2-benzyloxycarbonyloctadecanoic acid 13, which was prepared in two
steps from dibenzyl malonate, furnished the α,δ-bisamide 14 as inseparable mixture of
diastereomers (1:1). Reaction of 14 with excess sodium hydride resulted in tandem
Dieckmann condensation and deacylation to furnish tetramic acid 15 as a 1:1 mixture of
epimer at C3 of the 3,5-dioxopyrrolidine. The carboxylbenzyl group is generally removed
by catalytic hydrogenation. However, there is no evidence that sodium hydride could
remove carboxylbenzyl group directly. A possible mechanism might be nucleophilic
attack of the liberated sodium methoxide on the carbonyl of the benzyl ester. The
tetrahedral intermediate can either return to an ester or else lose a dialkyl carbonate to
generate a highly stabilized enolate. This mechanism is probably related to the removal
of ethoxycarbonyl group from 6 to7 in Scheme 2
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Scheme 3. Synthesis of target molecule

The synthetic tetramic acid was compared with the enzymatically synthesized material by
LC/MS and found to have the same retention time and to generate the same mass spectra.

4.3 Experimental Section
L-ornithine monohydrochloride, 9-borabicyclononane complex (9)
O
O

NH2
B

NH2

9

HCl
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Compound

9

was

prepared

by the

procedure

of

Fields

from

L-ornithine

monohydrochloride.4 The product, which retained solvent, was carried on into the next
procedure without purification.
N5-octadecanoyl-L-ornithine, 9-borabicyclononane complex (10)
O

O

O

N
H
B

C 17 H3 5

NH2

10
To a solution of compound 9 (3.06 g, 10 mmol) in THF 100 ml was added Et3N (6.0 ml,
40 mmol) and stearoyl chloride (4.30 g, 12 mmol). The reaction mixture was stirred at rt
for 6 h and then concentrated in vacuo. The residue was dissolved in 200 ml water, and
the aqueous layer was extracted with CH2Cl2 (100 ml × 3). The combined organic layers
were dried over anhydrous Na2SO4 and filtered. The residue obtained upon concentration
was purified by chromatography (CH2Cl2/MeOH, 95:5) to afford the octadecanoic amide
as a white solid 10 (4.40 g, 86%), Rf 0.6 (CH2Cl2/MeOH 90/10), Mp 69-70 °C. [α]D = 13.8 (CHCl3, c = 1.0). IR 3344, 3128, 3110, 2920, 2850, 1692, 1681, 1544, 1376, 1273,
963, 878, 722 cm-1; 1H NMR: δ6.60 (t, J= 6.4 Hz, 1H), 5.92 (t, J= 8.8 Hz, 1H), 5.01 (t,
J= 9.6 Hz, 1H), 3.78 (t, J= 6.3 Hz, 1H), 3.28 (m, 1H), 3.20 (m, 1H), 2.16 (t, J= 7.1 Hz,
2H), 2.05 (m, 1H), 1.94-1.12 (45H), 0.88 (t, J= 6.9 Hz, 3H), 0.57 (d, J= 10.8 Hz, 2H); 13C
NMR: 175.0, 174.3, 55.1, 38.7, 36.7, 31.9, 31.7, 31.4, 31.3, 31.2, 29.73, 29.67, 29.58,
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29.44, 29.41, 29.36, 28.1, 26.4, 25.9, 24.5, 24.0, 22.7, 14.1; HRMS (m/z) calcd for
C31H59BN2NaO3 [M+Na]+ : 541.4516; found: 541.4471

L-ornithine, N5-octadecanoylamide, methyl ester (11)
O

O

Me O

N
H

C 17 H35

NH 2

11
Ethylene diamine (1.7 ml, 25 mmol) was added to a solution of N5-octadecanoyl-Lornithine, 9-borabicyclononane complex (2.80 g, 5.5 mmol) in THF (15 ml).4 The
solution was heated to just below boiling for 1 min, and then cooled and filtered. The
precipitate was washed with THF (25 ml × 3), and dried in vacuo to give a white solid,
which was suspended in MeOH (100 ml). SOCl2 (1.9 ml, 25 mmol) was added dropwise,
and the reaction mixture was refluxed for 2 h. After removal of solvent in vacuo, the
residue was dissolved in water 100 ml. The solution was adjusted to pH 10 with sat. aq.
K2CO3, and then extracted with CH2Cl2 (50 ml × 3). The combined organic layers were
dried over anhydrous Na2SO4, and the filtrate concentrated in vacuo to afford 11 as a
white solid (2.26 g, 92%), which was used without further purification. Rf 0.3
(CH2Cl2/MeOH/NEt3 90/10/1),

Mp 59-61 °C; [α]D = -7.1 (CHCl3, c = 1.0). IR 3318,

2916, 2848, 1741, 1646, 1553, 1232, 718 cm-1; 1H NMR: 6.01 (t, J= 5.4 Hz, 1H), 3.70 (s,
3H), 3.44 (t, J= 6.9 Hz, 1H), 3.24 (m, 2H), 2.13 (t, J = 7.2 Hz, 2H), 1.60 (m, 4H), 1.301.21 (32H), 0.86 (t, J = 6.9 Hz, 3H); 13C NMR: 176.2, 173.2, 54.0, 52.1, 39.0, 26.8, 32.1,
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31.9, 29.67, 29.63, 29.5, 29.37, 29.33, 25.9, 25.8, 22.7, 14.1; HRMS (m/z) calcd for
C24H48N2NaO3 [M+Na]+ : 435.3563; found: 435.3562. Small impurities could be seen in
1

H NMR at 3.65 ppm and 2.28 ppm

2-(Benzyloxycarbonyl)octadecanoic acid, benzyl ester (12)
O

O

BnO

OBn
C16H33

12
Dibenzylmalonate (2.84 g, 10 mmol) was added to a stirred solution of NaH (0.24 g, 10
mmol) in dry THF (10 ml) and dry DMF (10 ml) and the mixture was stirred at rt for 1 h.
1-Iodohexadecane (3.52 g, 10 mmol) was then added and the reaction mixture was
refluxed for 3 h. The cooled reaction mixture was concentrated in vacuo and the residue
added to sat. aq. NH4Cl (100 ml), and the aqueous layer was extracted by Et2O (100 ml ×
3). The combined organic layers were dried over anhydrous Na2SO4 and the filtrate was
concentrated in vacuo. Flash chromatography (Hexane/EtOAc, 95:5) afforded the diester
as a low-melting white solid 12 (4.67 g, 92%). Rf 0.3 (Hexane/EtOAc 95/5). Mp 41-42 °
C; IR 2914, 2848, 1752, 1728, 1463, 1455, 1184,1143, 724, 669 cm-1; 1H NMR: δ7.34
(m, 10H), 5.19 (s, 4H), 3.48 (t, J= 7.5 Hz, 1H), 1.97 (dd, J= 7.1 Hz, 13.8 Hz, 2H), 1.381.21 (28H), 0.93 (t, J= 7.0 Hz, 3H); 13C NMR:δ169.3, 135.5, 128.6, 128.3, 128.2, 67.0,
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52.1, 32.0, 29.73, 29.69, 29.64, 29.5, 29.4, 29.3, 29.2, 28.8, 27.2, 22.7, 14.2 ; HRMS (m/z)
calcd for C33H48NaO4 [M+Na]+: 531.3450; found: 531.3411

2-(Benzyloxycarbonyl)octadecanoic acid (13) was prepared by a modification of a
procedure reported for malonic acid monobenzyl ester
O

O

BnO

OH
C 1 6H 3 3

13
To a suspension of KOH (0.28 g, 5 mmol) in benzyl alcohol (5.0 ml) was added
gradually to a solution of the diester (2.62 g, 5 mmol) in benzyl alcohol (25 ml). The
reaction mixture was stirred at rt for 24 h, and the solvent was then removed in vacuo.
The residue was dissolved in water (100 ml) and the solution acidified to pH 2 with 3 M
HCl. The aqueous layer was extracted with CH2Cl2 (100 ml × 3) and then combined
organic layers were dried over anhydrous Na2SO4. The filtrate was concentrated in vacuo
to afford a solid which was recrystallized from heptane to afford the monoester as a white
solid 13 (1.69 g, 81%): Rf 0.6 (Hexane/EtOAc/AcOH 20/20/1). Mp 46-48 °C; IR 2916,
2848, 1745, 1696, 1470, 1259, 1231, 936, 730, 718 cm-1; 1H NMR: δ10.08 (br, 1H),
7.40 (m, 5H), 5.23 (s, 2H), 3.47 (t, J= 7.4 Hz, 1H), 1.97 (m, 2H), 1.40-1.24 (28H), 0.92 (t,
J= 6.7 Hz, 3H);

13

C NMR: 175.2, 169.3, 135,3, 128.6, 128.4, 128.2, 67.3, 51.7, 32.0,
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29.73, 29.69, 29.63, 29.5, 29.39, 29.31, 29.2, 28.9, 27.2, 22.7, 14.1; HRMS (m/z) calcd
for C26H42NaO4 [M+Na]+: 441.2981; found: 441.2993.
L-ornithine,N5-octadecanoylamide-N2-(2-benzyloxycarbonyl)octadecanoylamide (14)
O

O

MeO

N
H
C1 6H3 3

HN

C1 7 H3 5

COOBn
O

14
To a solution of compound 11 (0.20 g, 0.48 mmol) in CH2Cl2 (20 ml) was sequentially
added N,N'-dicyclohexylcarbodiimide (0.12 g, 0.58 mmol) and monoester 13 (0.20 g,
0.48 mmol). The reaction mixture was refluxed for 4 h, cooled to rt, and then filtered.
The filtrate was dried over anhydrous Na2SO4, and then refiltered before being
concentrated in vacuo. Flash chromatography (Hexane/EtOAc, 60:40) afforded 14 as a
white solid (0.28 g, 72%), Rf 0.4 (Hexane/EtOAc 50/50). Mp 100-101 °C; IR 3304, 2916,
2849, 1736, 1639, 1545, 1272, 1236, 720, 695 cm-1; 1H NMR: δ7.37 (m, 5H), 7.17 (d,
J= 7.5 Hz, 0.5H), 7.13 (d, J= 7.8 Hz, 0.5H, isomer), 5.72 (t, J= 6.3 Hz, 1H), 5.20 (m, 2H),
4.58 (m, 1H), 3.75 (s, 1.5H), 3.74(s, 1.5H, isomer), 3.31 (dd, J= 7.1, 14.3 Hz, 1H), 3.24
(m, 2H), 2.15 (m, 2H), 1.86 (m, 4H), 1.65-1.25 (60H), 0.89 (t, J= 6.9 Hz, 6H); 13C NMR
173.38,

173.31(isomer),

172.3,

172.2(isomer),

171.7,

171.4(isomer),

168.4,

168.3(isomer), 135.32, 135.29(isomer), 128.6, 128.5, 128.4, 67.2, 52.95, 52.86(isomer),
52.51, 52.48(isomer), 51.93, 51.91(isomer), 38.6, 26.8, 31.9, 30.9, 30.5, 29.71, 29.66,
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29.5, 29.40, 29.37, 29.22, 29.17, 27.25, 27.21, 25.8, 25.4, 22.7, 14.1 ; HRMS (m/z calcd
for C50H88N2NaO6 ) [M+Na]+: 835.6540; found: 835.6465.
3-Hexadecyl-5-(3-aminopropyl)-pyrrolidine-2,4-one, octadecanoyl amide (1) was
prepared using a modification of a procedure reported for other tetramic acids.
O

O

C16H33

N
H

C17 H35

NH
O

1
NaH (60% dispersion in mineral oil, 13 mg, 0.37 mmol) was washed with pentane 20 ml
three times in a 100ml RB flask, then compound 14 (81 mg, 0.10 mmol) was added in
THF (10 ml). The reaction mixture was refluxed for 6 h and then cooled to rt. After
removal of solvent in vacuo, the residue was suspended in water (15 ml) and the solution
acidified to pH 2 with 3 M HCl. The combined CH2Cl2 extracts (10 ml × 3) were dried
over anhydrous Na2SO4 and the filtrate concentrated in vacuo. Flash chromatography
(CH2Cl2/MeOH, 95:5) afforded 1 as a white solid (48 mg, 74%). Rf 0.5 (CH2Cl2/MeOH
90/10). Mp 108-109 °C. IR 2916, 2848, 1686, 1639, 1467, 720 cm-1; 1H NMR: δ6.94 (d,
J= 3.9 Hz, 0.5H), 6.88 (d, J= 8.4 Hz, 0.5H, isomer), 5.60 (t, J= 5.4 Hz, 1H), 4.01 (t, J=
6.7 Hz, 0.5H), 3.92 (t, J= 5.4 Hz, 0.5H, isomer), 3.29 (m, 2H), 2.83 (t, J= 5.8 Hz, 0.5H),
2.76 (t, J= 5.8 Hz, 0.5H, isomer), 2.17 (t, J= 7.6 Hz, 2H),1.91-1.56(8H), 1.47-1.20 (56H),
0.90 (t, J= 6.6 Hz, 3H);

13

C NMR (150 MHz): 211.1, 210.7 (isomer), 174.2, 173.9

(isomer), 173.6, 62.3, 61.9(isomer), 49.7, 49.1(isomer), 38.5, 36.8, 31.9, 29.71, 29.67,
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29.58, 29.52, 29.37, 29.34, 29.31, 28.7, 27.2, 26.6, 26.5, 26.20, 25.9, 25.8, 25.5, 22.7,
14.1; HRMS (m/z) calcd for C41H78N2NaO3+ [M+Na]+: 669.5910; found: 669.5889

LC/MS analysis
Tetramic acid 1 was subjected to LC/MS under the following conditions:
LC/MS column Alltima C18LL (5u, 1.0mm * 250 mm); solvent A H2O containing 5 mM
ammonium acetate; solvent B MeOH containing 5 mM ammonium acetate. Flow rate
was 50 µl/min, with a gradient system (0-5 min, 30% B; 5-20 min, 30% B to 100% B
gradient; 20-30 min, 100% B; 30-40 min, 100% B to 30% B gradient; 40-45 min, 30% B).
One of the main signals observed, at 25.8 minutes, coincided exactly with the signal
observed for material derived from the biosynthetic pathway described in the introduction.
For both the synthetic material and the material derived from the biosynthetic pathway,
the peak at 25.8 minutes gave a mass spectrum the major peak at 647.6080.
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